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ABSTRACT OF DISSERTATION

THE ROLE OF MACROPHAGES IN OLFACTORY NEUROGENESIS
Olfactory sensory neurons (OSNs) undergo continual degeneration and
replacement throughout life, a cycle that can be synchronized experimentally by
performing olfactory bulbectomy (OBX). OBX induces apoptosis of mature OSNs,
which is followed by an increase in the proliferation of progenitor basal cells.
Macrophages, functionally diverse immune effector cells, phagocytose the apoptotic
OSNs and regulate the proliferation of basal cells. This provides an advantageous
environment to study how macrophages regulate neuronal death, proliferation, and
replacement.
The purpose of this dissertation was to identify the cellular and molecular
mechanisms by which macrophages regulate the degeneration/proliferation cycle of
OSNs. Macrophages were selectively depleted using liposome-encapsulated clodronate
(Lip-C). Intranasal and intravenous administration of Lip-C decreased the number of
macrophages in the OE of sham and OBX mice by 38% and 35%, respectively, compared
to mice treated with empty liposomes (Lip-O). Macrophage depletion significantly
decreased OE thickness (22% and 21%, p<0.05), the number of mature OSNs (1.2- and
1.9-fold, p<0.05), and basal cell proliferation (7.6- and 3.8-fold, p<0.05) in sham and
OBX mice, respectively, compared to Lip-O mice. Additionally, at 48 h following OBX,
OSN apoptosis increased significantly (p<0.05) in the OE of Lip-C mice compared to
Lip-O mice.
A microarray analysis was performed to identify the genomic changes underlying
the cellular changes associated with macrophage depletion. There were 4,024 genes with

either a significant interaction between group (Lip-C vs. Lip-O) and treatment (OBX vs.
sham) or a significant main effect. There were a number of significantly regulated
immune response and cytoskeletal genes, and genes encoding neurogenesis regulators
and growth factors, most of which were expressed at lower levels in Lip-C mice
compared to Lip-O mice. Sdf1, the ligand for the chemokine receptor Cxcr4 involved in
leukocyte trafficking, axon guidance, and cell migration, was localized to macrophages
on the protein level. Additionally, the microarray expression pattern of Hdgf, a growth
factor that promotes neuronal survival and proliferation, was validated on the protein
level using immunohistochemistry. HDGF appeared to be localized to basal cells and
OSNs where it could act as a proliferative or survival factor whose expression is
regulated in part by macrophages.
KEYWORDS: Macrophages, Liposome-encapsulated Clodronate, Neurogenesis, Gene
Expression, Olfactory Sensory Neurons
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CHAPTER ONE

Background
The Impact and Prevalence of Nervous System Damage and Disease
A coworker that was in a car crash and is relegated to a wheelchair, unable to use
their legs. An older relative with Alzheimer’s disease forgetting who they are talking to
or what year it is. A thirty-something friend with multiple sclerosis losing coordination
in their legs and hands. We have all seen the physical and emotional consequences of
someone suffering from an injury to the nervous system at one point or another in our
lives. The damage suffered by these people we know or even love is often traumatic and
heartbreaking, and often leaves us asking the question “isn’t there anything that can be
done to help them?”
Thusly, the inability of the nervous system to efficiently and properly, and in
some cases at all, regenerate and restore function following injury and trauma has been a
major focus of a number of scientific investigators over the years. Justifying this intense
search for the mechanisms of and treatments to these debilitating disorders are the
millions of people from all age groups, races, and social classes that are victims of
nervous system injuries and diseases. In fact, more than 600 neurological disorders affect
about 50 million Americans combined each year (National Institutes of Health). Spinal
cord injury alone affects between 250,000 and 400,000 people in the United States (The
National Spinal Cord Injury Association), causing many sufferers to spend the rest of
their lifetime in wheelchairs due to the neurons in the spinal cord either dying or failing
to regenerate to their appropriate targets, leaving the victim with little to no ability to
move their legs and/or arms and often depending on respirators to breathe.
Other diseases, such as multiple sclerosis (MS), a disease that affects
approximately 400,000 Americans (National Multiple Sclerosis Society), become more
debilitating over time as a result of increased demyelination and/or degeneration of
axons. In MS, an overactive immune system degrades components necessary for nervous
system signaling, leaving the victim increasingly unable to control muscle movement
over time (Sobel, 1995). MS patients also experience other symptoms including
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numbness, weakness, visual impairment, loss of balance, dizziness, urinary bladder
urgency, fatigue, and depression (Calabresi, 2004). These nervous system diseases have
resulted in billions of healthcare dollars spent per year, in addition to the mental and
physical anguish experienced by the victims of these diseases and their families.
Neurodegeneration and Neurogenesis: Implications for the Immune System
For many years it was commonly thought that neurons did not possess the
capacity for renewal and regeneration, and that these shortcomings were the reason for
the lack of repair in the nervous system. However, it is now known that in most cases
neurons are capable of regenerating their axons (Bomze et al., 2001; Schwab, 2002).
Despite this capacity for regrowth and renewal, diseases of and damage to the nervous
system remain largely untreatable, primarily due to our lack of understanding of the
immune response in neuronal damage. The impact the immune system has on the
response to neuronal damage has become increasingly significant to investigators. For
evidence of this one only has to look at two major debilitating disorders of the nervous
system in which activated immune cells reside: MS and spinal cord injury.
MS is characterized as a primary neuroinflammatory disease where the immune
system recognizes “self” as “non-self,” and therefore mounts an immune response against
neurons and myelinating cells, called oligodendrocytes, in the brain (Benveniste et al.,
2001; Bruck, 2005), resulting in neuroinflammation, neurodegeneration, and
demyelination of neurons (Figure 1.1A). Spinal cord injury, like Alzheimer’s and
Parkinson’s diseases, is characterized as a primary neurodegenerative disease that results
from an initial non-immune-mediated injury. In this case, macrophages (also known as
microglia in the central nervous system) and T cells infiltrate the damaged tissue and
induce a secondary inflammatory response that leads to progressive neurodegeneration
(Figure 1.1B).
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Figure 1.1. Interactions between immune-mediated inflammation and
neurodegeneration. (A) Primary neuroinflammatory diseases, such as MS, are a result of
activated immune cells, including macrophages (orange with black nucleus) and T cells
(orange) attacking parts of the brain, leading to demyelination, axon transection, or
neuronal death. (B) In primary neurodegenerative diseases, including Alzheimer’s and
spinal cord injury, non-immune-mediated neurodegeneration results in the infiltration of
macrophages and T cells leading to further demyelination, axon degeneration, and
neuronal death induced by secondary inflammation. Revised from (Zipp and Aktas,
2006).
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Macrophages and microglia are functionally diverse immune effector cells that
were recognized as the “third element” in the CNS by del Rio Hortega in 1919 as
referenced by Gebicke-Haerter (2001). Infiltrating macrophages are primarily
responsible for phagocytosing the cellular debris caused by the injury. This process
makes the environment conducive to axonal regrowth (David and Ousman, 2002).
However, release of pro-inflammatory cytokines, including IL-1 (interleukin-1), IL-6
(interleukin-6) and TNFα (tumor necrosis factor α) by resident and infiltrating
macrophages leads to the production of ROS (reactive oxygen species), iNOS (inducible
nitric oxide synthase), and other inflammatory mediators that are toxic to cells (Allan and
Rothwell, 2001), as is the case in primary neuroinflammatory diseases like MS. In
addition to the secretion of pro-inflammatory and cytotoxic mediators, macrophages
secrete a number of enzymes that degrade extracellular matrix components in
neurodegenerative diseases (Duffield, 2003). This process aids in the clearance of debris
enabling cells to regenerate, but also destroys the scaffolding needed for the regrowth and
restoration of tissue in disease.
The Immune-Nervous System Axis: Not Just Detrimental
While it may appear that macrophages are damaging to the neurons at the site of
injury, they also possess the capacity for secreting and inducing other cells to secrete
molecules that promote repair and regrowth of neurons and myelinating cells. For
example, following neuronal injury and secretion of cytotoxic mediators, macrophage or
macrophage-induced astrocyte secretion of TGF-β (transforming growth factor β), CNTF
(ciliary neurotrophic factor), IGF-1 (insulin-like growth factor 1), BDNF (brain-derived
neurotrophic factor), and/or NGF (nerve growth factor) have all been shown to promote
neurogenesis and remyelination of neurons (Hamada et al., 1996; Heese et al., 1998;
Herx et al., 2000; Kerschensteiner et al., 1999; Mason et al., 2003; Nguyen et al., 2002).
Following the initial phase of macrophage activation, phagocytosis, and
molecular secretion in response to neuronal injury, macrophages serve as antigenpresenting cells to infiltrating T cells (Popovich et al., 1993). T cells act as a secondary
response mechanism to activate adaptive immunity. This secondary response has been
reported to facilitate neuroprotection (Moalem et al., 1999) by enhancing phagocytosis of
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cellular debris and inducing secretion of neurotrophins by macrophages (David and
Ousman, 2002).
It is evident that the extent to which macrophages induce cytotoxicity or
neuroprotection and repair depends on the time course following injury and the molecular
cues received by the macrophages not only in spinal cord injury and multiple sclerosis,
but also in other models of neurodegeneration, including Alzheimer’s disease,
Parkinson’s disease, and age-related macular degeneration. The immune system is
capable of creating an environment conducive to neurogenesis through clearance of
cellular debris and secretion of neurotrophic mediators, but must receive the appropriate
signals to do so. Because of these capabilities, macrophages have unofficially adopted
the “Dr. Jekyll and Mr. Hyde” moniker (Duffield, 2003). Therefore, the goal of many
researchers is to better understand what directs the immune system down the road to
neuroprotection and tissue remodeling (Dr. Jekyll) rather than the road to
neurodegeneration (Mr. Hyde), and what the cellular and molecular consequences of this
beneficial response are. Once the identity and activity of these directing factors are
discovered and their mechanism of action well understood, they may be harnessed and
developed into potential immunotherapies for treating autoimmune neurological diseases,
a field of study gaining more attention over the past few years.
For example, immunotherapy has been utilized to protect neurons and
myelinating cells in mouse models of Parkinson’s and Alzheimer’s diseases, rat spinal
cord injury, multiple sclerosis, and other neurodegenerative disorders (Benner et al.,
2004; Blasko and Grubeck-Loebenstein, 2003; Mouzaki et al., 2004; Schwartz and Yoles,
2005; Schwartz and Yoles, 2006; Schwartz and Paul, 1993). Additionally, the
administration of anti-inflammatory cytokines have developed into potential inhibitors of
CNS diseases (Benveniste et al., 1996). These anti-inflammatory cytokines, including
IFN-β (interferon β), IL-4 (interleukin 4), IL-10, IL-13, and TGF-β, are molecules
expressed and secreted primarily by macrophages and T cells. These discoveries, while
still relatively raw and untapped, create an exciting and stimulating environment for
studying neuroimmunology.
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A Unique Environment for Neurogenesis: Advantages of the Olfactory System
One model for studying the degeneration and replacement of neurons is the
murine olfactory system. The olfactory system provides a unique approach for studying
the mechanisms that regulate neuronal survival, apoptosis, and replacement through the
proliferation of progenitor basal cells; and may be utilized as a window for understanding
these mechanisms within neurological disorders. Olfactory sensory neurons (OSNs)
undergo continual degeneration and replacement throughout life, with a lifespan of about
30-60 days (Graziadei et al., 1978; Schwob, 2002). In contrast to the previously
mentioned neurodegenerative CNS diseases, where neurons are required to regenerate
their axons to restore functionality, new OSNs are derived de novo from a set of basal
progenitor cells, called globose basal cells (GBCs). These GBCs proliferate into OSN
precursors, which then differentiate into immature OSNs that mature to become
functional OSNs (Calof et al., 1996). Mature OSNs are bipolar neurons whose cell
bodies reside in the middle layer of the olfactory epithelium (OE; Figure 1.2) with
dendrites that project apically to the mucus layer that covers the OE. Cilia, which
possess the odorant receptors, emerge from the dendrites into the mucous layer. Each
OSN expresses only one odorant receptor gene. The axons from the OSNs travel to
second-order neurons in the glomeruli of the olfactory bulb (OB) through fasciculated
nerve bundles in the underlying stroma (Kasowski et al., 1999).
The olfactory system is an advantageous model for studying neurogenesis for a
number of reasons: 1) neurons continually die throughout life; 2) neuronal precursor
cells proliferate and differentiate into immature neurons that mature into functional
sensory neurons; and 3) the OE is layered making cellular identification relatively
straightfoward. Another advantage of the olfactory system that is highly utilized is that
the degeneration and turnover of OSNs can be synchronized by performing an olfactory
bulbectomy (OBX), whereby the synaptic targets of OSNs are removed and the OSNs are
axotomized, resulting in retrograde OSN apoptosis (Carson et al., 2005; Cowan et al.,
2001; Michel et al., 1994). Apoptosis of OSNs induced by OBX is followed by an
increase in basal cell proliferation in order to restore the population of functional mature
OSNs (Carr and Farbman, 1992).
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Figure 1.2. The cell types and layers of the olfactory epithelium (OE). Globose basal
cells (GBCs, pink) proliferate and differentiate into immature olfactory sensory neurons
(OSNs, green) that become functional mature OSNs (black). Horizontal basal cells
(HBCs, purple) are mainly responsible for development of the basement membrane.
Sustentacular cells (SCs, orange) are non-neuronal supporting cells. Macrophages (MΦ,
blue) also populate the OE. Modified from Graziadei.
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Involvement of the Immune System in the OSN Cycle
Another benefit to studying the synchronous degeneration and turnover of OSNs
induced by OBX is the involvement of the immune system, and in particular
macrophages, in the unique OSN cycle. Much like the primary neurodegenerative
diseases highlighted in Figure 1.1B, including Alzheimer’s disease and spinal cord injury,
macrophage activation and infiltration into the OE occurs following neuronal damage. In
the olfactory system, macrophages are responsible for phagocytosing dying OSNs
following OBX (Suzuki et al., 1995). However, unlike Alzheimer’s disease and spinal
cord injury, the secondary response of macrophages to OBX appears to be benefical
rather than inflammatory. For example, macrophage infiltration into the OE following
OBX has been reported to coincide with an increase in basal cell proliferation (Figure
1.3; Nan et al., 2001). Therefore, it is quite evident that macrophages regulate the
turnover of OSNs, not only after OBX, but perhaps also following exposure to airborne
contaminants that are toxic to the OE. However, as is the case in spinal cord injury,
multiple sclerosis, and other neurological disorders, the extent to which macrophages
regulate neuronal survival and replacement is not well understood. From this, it is
evident that the olfactory system is an advantageous model to study not only because it is
a sight of ongoing neurogenesis, but it is also an environment where macrophages
directly interact with neurons, both key processes when considering the debilitating
neurodegenerative disorders previously discussed.
While there are several macrophage-mediated mechanisms in the OE already
defined, there are many potential interactions between macrophages and the cells that
make up the OE that have yet to be identified and characterized. For example, what
mechanisms regulate macrophage activation following OBX-induced OSN apoptosis?
Do macrophages directly or indirectly signal to OSNs to induce degeneration or survival?
What are the molecular consequences of macrophage-mediated proliferation of basal
cells and degeneration or survival of OSNs (Figure 1.4, red)? Answers to these questions
and others will provide insight into novel mechanisms by which macrophages regulate
the OSN degeneration/proliferation cycle while serving as a gateway to more clinicallybased areas of neuroimmunology associated with neurodegenerative diseases.
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Figure 1.3. Time-course of GBC proliferation and macrophage infiltration following
bilateral olfactory bulbectomy (OBX). (A) The mean number of BrdU+ GBCs is greater
in OBX mice (black circles) than in sham mice (black squares) and peaks at 3-4 days post
OBX. (B) The mean number of macrophages in the OE is greater in OBX mice (black
circles) than in sham mice (black squares) and peaks at 3 days post OBX. (Nan et al.,
2001).
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Figure 1.4. Schematic of OBX-induced apoptosis of OSNs and the subsequent
macrophage activation, infiltration, and basal cell proliferation. Macrophages activated
by OBX-induced OSN apoptosis secrete the chemokines MIP-1α and MCP-1 to recruit
additional macrophages into the OE. Activated macrophages have been reported to
express the neuropoietic cytokine LIF that induces basal cell proliferation. The red
question mark and lines indicate the mechanisms that have yet to be clearly defined, and
are addressed in this dissertation. Abbreviations: OBX, olfactory bulbectomy; ON,
olfactory nerve; dOSN, dying OSN; mOSN, mature OSN; iOSN, immature OSN; LIF,
leukemia inhibitory factor; MIP-1α, macrophage-inflammatory protein 1α; MCP-1,
monocyte chemoattractant protein 1.

10

A Novel Method for Studying Macrophage Function: Liposome-Encapsulated
Clodronate
One novel method of studying the function of macrophages in local environments
is to selectively deplete macrophages using liposome-encapsulated clodronate (Figure
1.5A). This compound consists of many clodronate molecules surrounded by
phospholipid bilayers. Once administered, the liposome-encapsulated clodronate is
phagocytosed by macrophages and taken up into lytic vacuoles, whereby the cell’s
lysosomal phospholipases breakdown the liposomal bilayer (Figure 1.5B). This process
releases free bisphosphonate clodronate molecules inside the cell, resulting in apoptosis
of the macrophage (Van Rooijen and Sanders, 1994). Utilizing this method, combined
with parallel injections of liposomes without clodronate as a control, one can isolate the
specific mechanisms and molecules that are regulated by macrophages in a particular
tissue environment, for example the OE. This compound selectively targets macrophages
in much the same way as defining the function of a particular gene via a knockout mouse
model.
Liposome-encapsulated clodronate has been used to study the role of
macrophages in a number of conditions, tissues, and diseases. For example, by depleting
macrophages using clodronate it was reported that macrophage-derived tumor necrosis
factor α (TNFα) may limit replication of herpes simplex virus type 1 (HSV-1) in the
suprachiasmatic nuclei (SCN) region of the brain (Fields et al., 2006). Another study
reported that depletion of macrophages using clodronate abolished diabetes due to
decreased islet β-cell death (Calderon et al., 2006). Additionally, several studies have
reported that macrophage depletion resulted in impaired oligodendrocyte remyelination
in the central nervous system (Kotter et al., 2001; Kotter et al., 2005). In one model
depletion of macrophages enhanced neuroprotection by preventing the clinical
manifestations of the animal model of MS (Huitinga et al., 1990). From these studies and
others, it is evident that the functions of macrophages are broad and often bimodal among
the many tissues in which they reside. Therefore, liposome-encapsulated clodronate
provides an excellent method for isolating the functions of macrophages in diverse
conditions and environments, including the OE.
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A

B

Figure 1.5. Liposome-encapsulated clodronate structure and mechanism of action. (A)
The structure of liposome-encapsulated clodronate. The clodronate molecules (black
squares) are surrounded by phospholipid bilayers. (B) Mechanism of clodronate-induced
apoptosis of macrophages. The liposome-encapsulated clodronate is phagocytosed by
macrophages and taken up into lytic vacuoles where lysosomal phospholipases degrade
the phospholipid bilayer, freeing the clodronate molecules inside the cell, resulting in
apoptosis of the macrophage. Taken from http://www.clodronateliposomes.org.
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Overall Goal of Dissertation: Rationale and Clinical Relevance
The overall goal of my dissertation is to characterize the role of macrophages in
the degeneration/proliferation cycle of OSNs. To achieve this goal, I have introduced the
use of liposome-encapsulated clodronate 1) intranasally to deplete resident macrophages
in the OE and 2) intravenously to deplete a subpopulation of blood monocytes to limit
recruitment of macrophages into the OE following OBX; and studied the subsequent
cellular and molecular changes in the unperturbed OE and in the OE at 48 h following
OBX-induced OSN apoptosis. This time point following OBX (48 h) has been identified
as a key period for a number of cellular and molecular changes in the OE. Firstly, there
is an increase in both macrophage infiltration and basal cell proliferation at 48 h
following OBX (Figure 1.3; Nan et al., 2001). Secondly, immune response, growth
factor, cell cycle, and apoptosis genes have been reported to be differentially regulated at
48 h following OBX (Getchell et al., 2006; Getchell et al., 2005). Thirdly, apoptosis of
OSNs is still occurring at 48 h following OBX (Cowan et al., 2001). Therefore, studying
the cellular and molecular changes in the OE associated with macrophage depletion at 48
h following OBX will provide insight into the regulation of OSN apoptosis, basal cell
proliferation, growth factor activity, and the immune response by macrophages.
Being able to define and understand the role that macrophages play in regulating
OSN degeneration and turnover will not only build upon our knowledge of the functional
olfactory system, but will also construct a model for possible mechanisms of
macrophage-mediated neuronal survival and regeneration in neurodegenerative diseases.
Once these neuroprotective mechanisms in the OE are identified they may be translated
and integrated into clinical models of neurodegeneration, demyelination, and neuronal
injury in the hopes that they may be developed into treatments and therapies for those
coworkers, relatives, and friends suffering from these debilitating disorders.
Specific Aim 1 of Dissertation
Specific aim 1 of my dissertation is: to test the hypothesis that depleting
macrophages in the OE will lead to a decrease in OSN replacement following target
ablation (OBX). This specific aim is covered in Chapter 2 and resulted in a first author
publication in the Journal of Comparative Neurology (Borders et al., 2006). This aim
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focuses on the cellular changes, including OSN apoptosis and proliferation of basal cells,
that occur in the unperturbed OE and in the OE at 48 h following OBX-induced OSN
apoptosis as a result of macrophage depletion, and will provide insight into what extent
macrophages regulate the degeneration/proliferation cycle of OSNs and their progenitors.
Specific Aim 2 of Dissertation
Specific aim 2 of my dissertation is: to test the hypothesis that macrophage
depletion in the OE will lead to altered gene expression profiles. This specific aim is
covered in Chapter 3 and resulted in a first author manuscript submitted to Physiological
Genomics (2007). This aim focuses on the genomic changes that occur in the OE as a
result of macrophage depletion, OBX, or both, using a microarray analysis followed by
molecular and cellular validation of selected genes. Of particular interest in this aim is
the differential expression of immune response, growth factor, cell cycle, and apoptosis
genes between macrophage-depleted and control mice that will provide insight into the
molecular mechanisms that drive macrophage-mediated neuroprotection and
neurogenesis.
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CHAPTER TWO

Macrophage Depletion in the Murine Olfactory Epithelium Leads to Increased
Neuronal Death and Decreased Neurogenesis

Note: Chapter Two consists of a first-author publication (Borders et al., 2007a). In the
Results section of Chapter Two, I, Aaron Borders, contributed 100% to the research
shown in Figures 2.1, 2.2, 2.3, 2.4, and 2.5; and 50% to the research shown in Figure 2.6.
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Introduction
The dynamic interaction between macrophages and apoptotic cells has led to studies
implicating macrophages in diseases of and trauma to the nervous system (Schwartz,
2003; Kadiu et al., 2005). Macrophages and microglia, their central nervous system
(CNS) counterparts, mediate both innate and acquired immune responses through
phagocytosis, antigen presentation, and the secretion of pro-inflammatory factors;
additionally, they participate in the resolution of inflammation and tissue reorganization
and restitution through the secretion of anti-inflammatory and growth factors (Gordon,
1998; Gordon, 2002; Duffield, 2003; Martin and Leibovich, 2005). Both macrophages
and microglia can induce CNS neuronal damage by secreting neurotoxins and proinflammatory cytokines in diseases such as HIV type I (Xu et al., 2004; Jones and Power,
2006), amyotrophic lateral sclerosis (Graves et al., 2004), and Alzheimer’s disease (Meda
et al., 1995). Macrophages also modulate peripheral nerve damage and dysfunction
resulting from injury/transection (Brück et al., 1996; Liu et al., 2000), viral infection (Lee
et al., 2004) and autoimmune disease (Jung et al., 1993; Lee et al., 2004). Additionally,
several studies (Lotan and Schwartz, 1994; Schwartz and Moalem, 2001) have
demonstrated neuroprotective roles for macrophages and microglia as well. For example,
microglial activation reduced neuronal apoptosis in an ischemia/reperfusion model
(Nakagawa et al., 2006) and in an in vitro model of neurotoxicity (Mitrasinovic et al.,
2005). Microglia also induce neuronal process outgrowth and synaptic function
(Batchelor et al., 2002; Shibata et al., 2003) and contribute to neurogenesis and
oligodendrogenesis (Butovsky et al., 2006; Ziv et al., 2006).
Macrophage-mediated effects on neuronal survival, regeneration, and function are of
particular interest in the olfactory system, where olfactory sensory neurons (OSNs) die
and undergo continual replacement through the proliferation of basal cells and the
subsequent differentiation and maturation of their progeny into mature OSNs throughout
life (Graziadei and Monti Graziadei, 1978; Graziadei and Monti Graziadei, 1979;
Schwob, 2002). The mechanisms that drive this neurogenic cycle can be synchronized
experimentally by olfactory bulbectomy (OBX), which severs the axons of the OSNs,
resulting in their retrograde apoptosis via the caspase-3 pathway (Carr and Farbman,
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1992; Michel et al., 1994; Cowan et al., 2001) followed by a marked reduction in mature
OSN numbers and in the thickness of the olfactory epithelium (OE; Holcomb et al.,
1995). OBX-induced neuronal apoptosis activates resident OE macrophages (Nan et al.,
2001), which phagocytose apoptotic OSNs (Suzuki et al., 1995) and secrete chemokines,
most notably macrophage inflammatory protein-1α (MIP-1α) and monocyte
chemoattractant protein-1 (MCP-1), that recruit additional monocytes/macrophages into
the OE (Getchell et al., 2002c; Kwong et al., 2004). Activated macrophages also secrete
cytokines and growth factors (Nan et al., 2001; Getchell et al., 2002b; Bauer et al., 2003)
that stimulate the proliferation of basal cells that give rise to the OSN lineage (Schwartz
Levey et al., 1991; Huard et al., 1998; Calof et al., 2002; Carter et al., 2004). The
increase in basal cell proliferation and up-regulation of receptors for at least one
macrophage-derived growth factor on basal cells (Nan et al., 2001) coincide temporally
with the increase in macrophage infiltration into the OE following OBX. Additionally,
recent studies demonstrated that genes associated with apoptosis and proliferation as well
as macrophage activation and infiltration were significantly regulated in the murine OE
by 48 hr following OBX (Getchell et al., 2005; Shetty et al., 2005; Getchell et al., 2006).
Studies in several mouse models have supported the role of macrophages in the
apoptosis of OSNs and subsequent proliferation of basal cell progenitors. In Mip-1α
knockout mice, macrophage infiltration into the OE as well as OE thickness and basal
cell proliferation were significantly reduced at 3 days following OBX compared to wild
type mice and were restored to near-control levels by injection of MIP-1α into the
knockout mice (Kwong et al., 2004). Disruption of the gene encoding scavenger receptor
A, one receptor through which macrophages bind to apoptotic cells, resulted in
significantly decreased macrophage activation and recruitment as well as OE thickness
and basal cell proliferation in response to OBX compared to wild type mice (Getchell et
al., 2006). However, another mechanism has been proposed to regulate olfactory
epithelial cell dynamics following OSN apoptosis and has been substantiated
experimentally. Calof and co-workers have demonstrated that OSNs produce growth
factors such as bone morphogenetic protein 4 and growth and differentiation factor 11
that modulate OE neurogenesis (Shou et al., 2000; Wu et al., 2003). Thus, the extent to
which macrophages contribute to the regulation of the cellular and molecular
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mechanisms that maintain and generate the neuronal population in the OE through basal
cell proliferation and subsequent OSN differentiation, maturation, and survival has not
been clearly defined.
One approach to elucidating the contribution of macrophages to the cellular and
molecular mechanisms of neurogenesis in the OE is to specifically reduce the
macrophage population. One technique for accomplishing this is the use of liposomeencapsulated clodronate, which selectively induces apoptosis in monocytes and
macrophages (van Rooijen and Sanders, 1994). Liposome-encapsulated clodronate is
taken up exclusively by phagocytic cells. Upon phagocytosis of the liposomeencapsulated clodronate, the phospholipid bilayers are disrupted by lysosomal
phospholipases in the macrophage, freeing the clodronate inside the cell, which results in
apoptosis of the macrophage. The utility of this method in the nervous system has been
demonstrated in studies in which the injection of liposome-encapsulated clodronate
resulted in impaired remyelination and altered growth factor expression following
experimental demyelination in the CNS (Kotter et al., 2001; Kotter et al., 2005) as well as
a reduction in the severity of several neurological disorders (van Rooijen and van
Kesteren-Hendrikx, 2002).
The aims of this study were (a) to determine if resident OE macrophages could be
depleted by the systemic and local injection of liposome-encapsulated clodronate; (b) to
assess the effects of macrophage depletion on the unperturbed OE; and (c) to investigate
the effects of macrophage depletion on apoptosis and neurogenesis in the OE in response
to OBX.

Materials and Methods
Animals
Twelve 6-week old C57BL/6J male mice (Jackson Labs, Bar Harbor, Maine) were
maintained on a 12:12 hour light:dark cycle in the Department of Laboratory Animal
Research facilities and were given food and water ad libitum. All protocols were
implemented in accordance with the NIH guidelines and approved by the University of
Kentucky Institutional Animal Care and Use Committee.
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Selective Macrophage Depletion
Because activation of resident macrophages in the OE leads to recruitment of
circulating monocytes, our experimental approach was to deplete both resident
macrophages and blood monocytes using liposome-encapsulated clodronate. Liposomes
were prepared as previously described (van Rooijen and Sanders, 1994). Clodronate was
a gift from Roche Diagnostics Gmbh, Mannheim, Germany. Overlapping series of
injections were administered locally and systemically as described in Table 2.1. To
deplete OE macrophages, 6 mice were anesthetized with isoflurane and injected
intranasally (i.n.) with 50 µl of liposomes containing clodronate (Lip-C) once per day at 4
pm for 3 consecutive days. To deplete a subpopulation of blood monocytes
(Sunderkotter et al., 2004), the mice were injected intravenously (i.v.) with 200 µl of
Lip-C in the lateral tail vein on the first and third days of i.n. injections at the same time
of day. As controls, empty liposomes without clodronate (Lip-O) were injected in the
same manner and on the same schedule for controls (n=6).
Olfactory Bulbectomy (OBX)
To induce OSN apoptosis and basal cell proliferation, 3 mice per treatment underwent
bilateral olfactory bulbectomy (OBX) as described previously (Getchell et al., 2005) on
the second day of the injection series (Table 2.1). Mice were anesthetized with Avertin
(2,2,2-tribromoethanol and tert-amyl alcohol; Aldrich Chemical Co., St. Louis, MO; 300
mg/kg i.p.), and bilateral OBX was performed using vacuum aspiration with a glass
pipette. The resulting cavity was filled with sterile Gelfoam. Incisions were sutured,
followed by application of a topical antiseptic (Betadine). Three mice per treatment
underwent sham OBX as previously described (Getchell et al., 2005). All mice were
injected with 5-bromo-2’-deoxyuridine (BrdU; Sigma-Aldrich, Inc., St. Louis, MO; 100
mg/kg i.p.) in sterile saline 2 hr prior to euthanization. Mice were euthanized with an
overdose of sodium pentobarbital (Butler Company, Columbus, OH; 0.3 cc i.p.) at 48 hr
following either bilateral OBX or sham OBX.
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Table 2.1. Experimental schedule.
Treatment

Injection
Route/Surgery

Injection Volumes and Procedures
Day 4
Day 1
Day 2
Day 3

i.n.
50 μl
50 μl
50 μl
Euthanize
i.v.
200 μl
0 μl
200 μl
Surgery
Sham or OBX
i.n.
50 μl
50 μl
50 μl
Lip-C
Euthanize
i.v.
0 μl
200 μl
200 μl
(n=6)
Surgery
Sham or OBX
Volumes and days of injections, along with days of surgery and tissue harvesting. The
Lip-O
(n=6)

number of mice for each treatment is also given. Three mice from each treatment
underwent either sham or OBX. Abbreviations: Lip-O, empty liposomes; Lip-C,
liposomes containing clodronate; i.n., intranasal; i.v., intravenous; OBX, olfactory
bulbectomy.
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Tissue Harvesting
All mice were perfused with chilled sterile PBS (pH 7.4) followed by fixation with
chilled 3% paraformaldehyde (PFA). Lungs, spleens, guts, and nasal cavity tissues were
collected and placed in 3% PFA on ice for 2 hr, and were cryoprotected in 15-30%
sucrose in PBS. The following day, tissues were placed in fresh 30% sucrose for 1 hr,
then embedded in OCT and sectioned at 12 µm. Sections were mounted on Superfrost
Plus microscope slides (Fisher Scientific, Pittsburg, PA).
Immunohistochemistry
Two-step indirect immunofluorescence was used to visualize immunoreactivity for:
CD68 (macrophages), BrdU (proliferation), and olfactory marker protein (OMP, mature
OSNs; Margolis, 1988). Table 2.2 lists the specificities, sources and catalog numbers,
immunogens, preparation, hosts, and optimal dilutions for the primary antibodies used.
Sections were incubated in a blocking solution (2% BSA with 0.4% Triton X-100 in
PBS) for 30 minutes at room temperature. All primary antibodies were diluted in the
blocking solution and incubated overnight at 4°C. The monoclonal CD68 antibody has
been reported to stain one band (97 kD molecular weight) on Western blot (Rabinowitz
and Gordon, 1991). The polyclonal OMP antibody was reported to stain one band (19
kD) on Western blot, which was absent in homozygous OMP-null mice (Buiakova et al.,
1996).
To detect apoptotic cells, sections were incubated in 7.5% hydrogen peroxide in
100% methanol to block endogenous peroxidase activity and stained for active caspase-3,
then visualized using the Vectastain ABC Elite rabbit peroxidase kit (Vector Labs,
Burlingame, CA). The monoclonal active caspase-3 antibody stains two bands (17 kD
and 19 kD) corresponding to proteolytic cleavage products (p17 and p12 fragments; Cell
Signaling technical datasheet. The use of the monoclonal active caspase-3 antibody to
stain the presence of apoptotic cells in ischemic neuronal tissue has been demonstrated
(Cell Signaling technical datasheet). Additionally, the presence of active caspase-3 in the
OE at multiple time points following OBX has previously been reported (Cowan et al.,
2001).
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Table 2.2. Primary Antibodies.
Primary
Antibody

Specificity and Source

Immunogen

Preparation

Host

Dilution

Monoclonal

rt

1:50

CD68

Macrophages ( MCA 1957GA;
Serotec, Raleigh, NC)

Produced by a hybridoma line (FA/11)
generated by the fusion of spleen cells
from a mouse immunized with purified
ConA acceptor glycoproteins from the
P815 cell line.

BrdU

Proliferating cells (B 2531; SigmaAldrich, Inc., St. Louis, MO)

BrdU-KLH conjugate

Monoclonal

ms

1:250

Active
caspase-3

Apoptotic cells (#9664; Cell
Signaling, Danvers, MA)

KLH-conjugated peptide corresponding
to aa164-175 in hu caspase-3

Monoclonal

rb

1:50
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Mature olfactory sensory neurons
(a generous gift of F.L. Margolis,
OMP
Purified rat OMP
Polyclonal
gt
1:1000
University of Maryland School of
Medicine)
Abbreviations: rt, rat; BrdU, 5-bromo-2’-deoxyuridine; KLH, keyhole limpet hemocyanin; ms, mouse; aa, amino acid; hu, human; rb,
rabbit; OMP, olfactory marker protein; gt, goat.

Species-specific secondary antibodies (Jackson Immunoresearch, West Grove, PA)
used for immunofluorescence were IgGs conjugated to rhodamine red X (RRX) or
fluorescein isothyocyanate (FITC). RRX-conjugated secondary antibodies were used at
dilutions of 1:200 (CD68) and 1:150 (BrdU). FITC-conjugated secondary antibodies
were used at a dilution of 1:100 (OMP). All secondary antibodies were incubated in PBS
at room temperature for 1 hr in the dark. In order to co-localize CD68+ macrophages and
apoptotic bodies, sections were immunostained with CD68 as described above and the
nuclei counterstained with bisbenzimide (Hoechst 33258; Sigma-Aldrich, St. Louis,
MO). CD68-stained sections were incubated in a solution of 1:105 bisbenzimide in PBS
for 3 minutes at room temperature, rinsed in PBS, and coverslipped.
Spleen (CD68 and active caspase-3), gut (BrdU), and OE (OMP) were used as
positive immunohistochemistry controls. All positive controls showed specifically
distributed and morphological staining that has previously been reported (Rabinowitz and
Gordon, 1991; Buiakova et al., 1994; Resendes et al., 2004; Crosnier et al., 2005).
Negative controls for secondary antibody specificity were sections stained with primary
antibodies omitted from the staining protocol. All negative controls showed no specific
immunoreactivity. Near-adjacent sections from comparable nasal cavity regions of each
mouse were used for IHC.
Microscopy
Fluorescence microscopy was used to visualize and capture images of CD68, BrdU,
and CD68/bisbenzimide, while brightfield microscopy was used for active caspase-3
images. Brightness and contrast of digitally captured images were minimally enhanced
using Adobe Photoshop CS2 V9.0. Due to the large number of mOSNs in the OE,
confocal microscopy at the University of Kentucky Imaging Center was used to visualize
and capture images of OMP. Each OMP image represents the maximum signal for six 1
µm thick optical sections. All photomicrographs are of OE on the nasal septum and are
representative images of 3 mice per treatment for each surgery.
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Macrophage Depletion and Cellular Quantification
To ensure that macrophage depletion was comparable to published data (Leemans et
al., 2001), 2 sections of lung from 3 sham mice per treatment were stained for the
presence of CD68. CD68-immunoreactive cells were counted in an area of 0.2 mm2 at 5
random locations per section and averaged for each mouse. To quantify macrophage
depletion in the OE, cells immunoreactive for CD68 were counted in five 0.25 mm
segments of OE on each side of the septum and on turbinate IIa, which was chosen as a
representative turbinate. This was done for 3 slides (2 sections per slide, 6 total sections)
per mouse using 3 mice per treatment for sham and OBX surgeries. Slides from the same
region of the nasal cavity approximately 100 µm apart were used for all mice. The
average size of the nuclei of macrophages in the OE of sham and OBX mice was
previously reported to be not significantly different (Nan et al., 2001); therefore the
uncorrected cell counts per unit length provide a reasonable estimate of the macrophage
population density in the OE.
In order to quantify OMP+ mOSNs in the OE, OMP-immunoreactive cells with a
defined nucleus were counted in two 0.25 mm segments of OE on each side of the
septum and one 0.25 mm segment of OE on turbinate IIa. This was done for one section
per mouse using 3 mice per treatment for sham and OBX surgeries. Sections were from
the same region of the nasal cavity for all mice and near adjacent to those used for CD68
staining. To account for possible differences in OMP+ cell size, the nuclei of 10
randomly chosen OMP+ mOSNs per cell count segment were measured microscopically
in Lip-O sham (5.2 μm ± 0.2 μm), Lip-O OBX (5.1 μm ± 0.2 μm), Lip-C sham (5.1 μm ±
0.2 μm), and Lip-C OBX (5.0 μm ± 0.2 μm) mice. A one-way analysis of variance
(ANOVA) assuming equal variance indicated that there was no significant difference
(p=0.29) in nuclear sizes among the 4 mouse groups. Therefore, the uncorrected cell
counts per unit length of OE provide a reasonable estimate of the mOSN population
density for each mouse group. Quantification of BrdU+ proliferative basal cells in sham
and OBX mice was performed in the same manner as CD68 on near adjacent sections to
those used for CD68.
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Analysis of OE Thickness
To determine the effects of macrophage depletion on the thickness of the OE in sham
and OBX mice, the thickness of the OE was measured in the 5 segments on each side of
the septum and on turbinate IIa in which CD68+ cells were counted. The thickness of the
OE was measured as the distance between the basement membrane and the top of the
ciliary layer. Six sections per mouse using 3 mice per treatment for sham and OBX
surgeries were used to measure OE thickness.
Densitometry Analysis
NIH ImageJ (Version 1.24o) was used to estimate the intensity of active caspase-3
immunoreactivity in the OE. Following immunohistochemical detection of active
caspase-3, images were captured and analyzed using ImageJ by calculating the mean
density for all pixels in the chosen field. Two to 4 representative OE sections from
comparable regions of the nasal cavity were analyzed for each mouse. For each section,
three 0.25 mm image fields of OE on each side of the septum and 3-4 fields on turbinate
IIa were analyzed, and the mean pixel intensity averaged per mouse. To determine the
difference in active caspase-3 immunoreactivity between each treatment/surgery group,
the relative pixel intensity of active caspase-3 immunoreactivity was expressed on a scale
of 0-100%, with the average intensity of the Lip-O sham mice set to zero since there was
very little staining, and the average intensity of the Lip-C OBX mice set at 100%. The
formula for calculating the relative intensity of active caspase-3 immunoreactivity for
each treatment/surgery group is expressed as:
RIX = 100%*(XI – Lip-O ShamI)/(Lip-C OBXI – Lip-O ShamI)
where RIX = relative intensity of each treatment/surgery group, and XI = the average
intensity of each treatment/surgery group.
Statistical Analyses
For each of the quantifications, the value for each treatment/surgery group was taken
as the mean of data from 3 mice. A one-way ANOVA assuming equal variance was
performed on the means of the 4 groups for each analysis. The one-way ANOVA
determined that there was significance (p<0.005) among the 4 groups for each of the 5
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analyses. Pairwise t-tests were performed to determine significance (p<0.05) of the
differences between treatments for each surgery (Lip-O vs. Lip-C sham; Lip-O vs. Lip-C
OBX), and between surgeries for each treatment (Lip-O sham vs. OBX; Lip-C sham vs.
OBX).

Results
Macrophage Depletion Following Clodronate Treatment
To assess the effectiveness of clodronate-induced macrophage depletion, we stained
for the macrophage marker CD68 in lungs of Lip-O and Lip-C sham mice and counted
immunoreactive cells for statistical analysis (Figure 2.1). There was an 89% decrease in
the average number of CD68+ cells in the lung of Lip-C compared to Lip-O sham mice
(Figures 2.1A, B, and G; p<0.001). This result is comparable to previously published
data in the lung (Leemans et al., 2001) and demonstrates the effectiveness of the
macrophage apoptosis-inducing agent clodronate in the animals used in our study.
We then assessed the effect of Lip-C on macrophage depletion in the OE. There was
a 38% decrease in the average number of macrophages in the OE of Lip-C compared to
Lip-O sham mice (Figures 2.1C, D, and G; p<0.05), demonstrating that the injection
paradigm was effective. At 48 hr following OBX, there was a significant increase in the
average number of CD68+ cells in the OE of both Lip-O and Lip-C mice compared to
shams (Figures 2.1E, F, and G; p<0.005). However, the number of macrophages in the
OE of Lip-C OBX mice compared to Lip-O mice was significantly lower by 35%
(p<0.05). In addition to the significant decrease in the number of OE macrophages in the
Lip-C mice, the lamina propria of Lip-C mice appeared to have a reduced number of
macrophages compared to Lip-O mice (data not shown). These results demonstrate that
clodronate significantly decreased the number of resident OE macrophages in sham mice
and significantly reduced the number of macrophages recruited to and infiltrating the OE
of OBX mice.
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Figure 2.1. Immunohistochemical and quantitative analysis of macrophage depletion in
the lung and olfactory epithelium (OE). CD68+ cells (arrows) in the lung of sham mice
treated with either empty liposomes (Lip-O; A) or liposome-encapsulated clodronate
(Lip-C; B). CD68+ macrophages in the OE (delimited by arrowheads) of Lip-O sham (C)
and olfactory bulbectomized (OBX; E) mice compared to Lip-C sham (D) and OBX (F)
mice. Scale bar = 50 µm. (G) Statistical analysis showing significant macrophage
depletion in the lung, sham OE, and OBX OE of Lip-C compared to Lip-O mice. (H)
Lip-C sham and OBX mice had significantly thinner OE compared to Lip-O mice. # =
0.2 mm2 for lung, 0.25 mm for OE; * p<0.05, *** p<0.005 Lip-C vs. Lip-O; †† p<0.01,
††† p<0.005 OBX vs. sham.
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Olfactory Epithelial Thickness
To determine if there were any cellular changes in the OE associated with
macrophage depletion, we measured the thickness of the OE, an indicator of the
approximate size of the OSN population. The average thickness of the OE in Lip-C sham
mice was 21% less than that of Lip-O mice (Figure 2.1H; p<0.05). This suggests that
macrophages in the OE either directly or indirectly facilitate maintenance of the number
of OSNs in the unperturbed OE. Following OBX, there was a significant decrease in the
average thickness of the OE for both treatment groups compared to shams (Lip-O,
p<0.005; Lip-C, p<0.01). However, the average OE thickness of Lip-C OBX mice was
22% less than that of Lip-O mice (p<0.05), suggesting that macrophages modulate the
number of OSNs that survive following OBX.
OSN Apoptosis
To investigate the relationship between macrophage depletion in the OE and OSN
apoptosis, we stained for the presence of active caspase-3. Representative sections
immunostained for active caspase-3 from comparable regions of the nasal cavity of Lip-O
and Lip-C sham and OBX mice are shown in Figure 2.2. There was no apparent
difference in the immunoreactivity for active caspase-3 in Lip-O versus Lip-C sham mice
(Figures 2.2A and B). Interestingly, there was a substantial increase in active caspase-3
immunoreactivity in the OE and in sub-epithelial nerve bundles containing the axons of
OSNs in Lip-C compared to Lip-O mice at 48 hr following OBX (Figures 2.2C and D).
This difference in active caspase-3 staining was evident throughout the OE and in nerve
bundles of the septum and turbinate IIa, although less dramatic in the turbinate (data not
shown). Within the OE, active caspase-3 appeared primarily in the OSN layer, with a
few positive cells in the basal cell layer (BC). There was no active caspase-3 staining in
the supranuclear region of the sustentacular cell layer (SC) at the apical surface of the
OE.
Quantification of active caspase-3 immunoreactivity in the OE demonstrated that the
normalized relative mean pixel intensity of Lip-O sham mice was not significantly
different than that of Lip-C sham mice (Figure 2.2E; p>0.05). At 48 hr following OBX,
the relative intensity was significantly increased by both treatments compared to sham
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Figure 2.2. Immunohistochemical and quantitative analysis of the effects of macrophage
depletion on olfactory sensory neuron (OSN) apoptosis. Negligible numbers of active
caspase-3+ cells in the olfactory epithelium (OE; delimited by arrowheads) and nerve
bundles of sham mice treated with either empty liposomes (Lip-O; A) or liposomeencapsulated clodronate (Lip-C; B). Olfactory bulbectomy (OBX) increases
immunoreactivity for active caspase-3 in the OE and nerve bundles of both Lip-O (C)
and Lip-C (D) mice. Scale bar = 50 µm. (E) The normalized relative mean pixel
intensity of active caspase-3 immunoreactivity was significantly increased in the OE of
Lip-C compared to Lip-O OBX mice. BC = basal cell layer, OSN = olfactory sensory
neuron layer, SC = sustentacular cell layer. * p<0.05 Lip-C vs. Lip-O; † p<0.05, ††
p<0.01 OBX vs. sham.
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mice (Figure 2.2E; Lip-O, p<0.05; Lip-C, p<0.01). However, the relative intensity in the
OE of Lip-C OBX mice was significantly greater than that of Lip-O OBX mice (Figure
2.2E; p<0.05). These results demonstrate that depletion of macrophages leads to a
significant increase in apoptosis, primarily in OSNs, at 48 hr following OBX.
Because clodronate induces apoptosis in macrophages, dying macrophages in the OE
might have contributed to the increased active caspase-3 immunoreactivity in the Lip-C
mice. To evaluate that possibility, we co-localized CD68+ macrophages and apoptotic
bodies visualized by bisbenzimide staining. There were very few apoptotic bodies in
either the Lip-O or Lip-C sham mice (Figures 2.3A and B, arrows). At 48 hr following
OBX, there was a substantial increase in the presence of apoptotic bodies in the OE of
Lip-O mice (Figure 2.3C), and an even greater increase in the Lip-C mice (Figure 2.3D),
in concordance with the increase in apoptosis as indicated by active caspase-3
immunoreactivity (Figures 2.2C and D). Co-localization of apoptotic bodies and CD68
showed that the majority of apoptotic bodies in the OE of Lip-C mice were not associated
with CD68+ macrophages, demonstrating that the substantial increase in active caspase-3
immunostaining at 48 hr following OBX in Lip-C mice was not due to the presence of
apoptotic macrophages in the OE. It was also evident that the apoptotic bodies observed
in Figure 2.3 were localized primarily in the OSN layer, as were the active caspase-3+
cells in Figure 2.2. There did not appear to be any apoptotic bodies in the sustentacular
cell layer.
Mature OSN Population
To determine the effects of macrophage depletion on the mOSN population, we
stained for the mOSN marker olfactory marker protein (OMP). Analysis of
representative sections from comparable nasal cavity regions for each treatment indicated
a significant decrease in the number of OMP+ cells in the OE of Lip-C compared to LipO sham mice (1.2 fold; Figures 2.4A, B, and E; p<0.05). At 48 hr following OBX, there
was a significant decrease in OMP+ cells for both treatments (5.4 fold for Lip-C, 3.6 fold
for Lip-O; Figures 2.4C, D, and E; p<0.005). There was an apparent decrease in OMP
immunoreactivity in the ciliary layer, apical to the sustentacular cell (SC) layer, for both
treatments, also indicative of a decrease in the number of mOSNs. The number of OMP+
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Figure 2.3. Co-localization of CD68+ cells (red) and apoptotic bodies (solid cyan circles;
examples given by arrows) in the olfactory epithelium (OE; delimited by arrowheads).
(A) In the empty liposome (Lip-O) sham mice there were several CD68+ cells and very
few apoptotic bodies. (B) Liposome-encapsulated clodronate (Lip-C) sham mice had
reduced numbers of CD68+ cells and contained few apoptotic bodies which were not
localized with CD68+ cells. Olfactory bulbectomy (OBX) increased the number of both
CD68+ cells and apoptotic bodies in Lip-O mice (C). Lip-C OBX mice (D) showed a
dramatic increase in the number of apoptotic bodies, the majority of which were not
localized with CD68+ cells. The inset in D shows an enlarged region of OE containing
several apoptotic bodies. Apoptotic bodies were present primarily in the olfactory
sensory neuron (OSN) layer, with a few in the basal cell (BC) layer. No apoptotic bodies
were observed in the sustentacular cell (SC) layer. Nuclei were stained with
bisbenzimide. Scale bar = 50 µm.
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Figure 2.4. Confocal images of olfactory marker protein (OMP) in the olfactory
epithelium (OE; delimited by arrowheads) in sham and olfactory bulbectomized (OBX)
mice treated with either empty liposomes (Lip-O) or liposome-encapsulated clodronate
(Lip-C). OMP immunoreactivity was abundant in Lip-O (A) and Lip-C (B) sham mice.
At 48 hr following OBX, there is a decrease in OMP immunoreactivity in Lip-O (C) and
Lip-C (D) mice in both the olfactory sensory neuron (OSN) layer and the ciliary layer
apical to the sustentacular cell (SC) layer. There was a more dramatic decrease in OMP
staining for Lip-C compared to Lip-O OBX mice in both the OSN and ciliary layer, and
an increase in the thickness of OMP-immunoreactive dendrites (projecting through SC
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layer) of the OSNs. A large proportion of OMP immunoreactivity in the Lip-C OBX
mice appeared to be localized in cells undergoing apoptosis (arrows). Scale bar = 20 µm.
(E) Statistical analysis showing the significant decrease in OMP+ mature OSNs in the OE
of Lip-C compared to Lip-O mice, and at 48 hr following OBX compared to sham mice.
BC = basal cell layer. * p<0.05 Lip-C vs. Lip-O; ††† p<0.005 OBX vs. sham.
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mOSNs decreased significantly in the Lip-C OBX mice compared to the Lip-O OBX
mice (1.9 fold; p<0.05). Similarly, there was less OMP staining in the ciliary layer of the
OE for the Lip-C OBX mice, and OMP+ dendrites appeared thicker in the Lip-C
compared to Lip-O mice. In addition, several OMP+ cells in the Lip-C mice appeared
apoptotic, as indicated by their dense staining and round morphology (arrows). These
results demonstrate a significant decrease in the mOSN population in Lip-C compared to
Lip-O mice.
Basal Cell Proliferation
To investigate the effects of macrophage depletion in the OE on basal cell
proliferation in sham and OBX mice, we stained for the proliferation marker BrdU.
There was a relatively high number of proliferative basal calls in the Lip-O sham mice
(Figure 2.5A), with no significant difference in the average number of BrdU+ basal cells
in the Lip-O mice at 48 hr after OBX (Figure 2.5C) compared to the Lip-O shams
(Figures 2.5A and E; p>0.05). In Lip-C sham mice, there was a 7.6 fold decrease in the
average number of BrdU+ basal cells when compared to the Lip-O sham mice (Figures
2.5A, B, and E; p<0.005). At 48 hr following OBX, there was a significant increase in
the average number of BrdU+ basal cells in the Lip-C mice (Figure 2.5D) compared to the
Lip-C shams (Figures 2.5B and E; p<0.05). Additionally, there were 3.8 fold fewer
proliferative progenitor cells in the Lip-C compared to Lip-O mice at 48 hr following
OBX (Figures 2.5D and E; p<0.005). These data suggest that macrophages in the OE
directly or indirectly regulate basal cell proliferation in normal and post-OBX conditions.

Discussion
The results of this study demonstrate that (1) liposome-encapsulated clodronate
administered through i.n. and i.v. routes significantly reduced the numbers of resident and
infiltrating macrophages in the OE with no apparent effects on the cellular integrity of the
OE; (2) selective macrophage depletion significantly decreased the thickness of the
unperturbed OE of sham OBX mice and of the OE at 48 hr after OBX; (3) selective
macrophage depletion significantly increased OSN apoptosis at 48 hr following OBX;
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Figure 2.5. Immunohistochemical and quantitative analysis of the effects of macrophage
depletion on basal cell proliferation in the olfactory epithelium (OE; delimited by
arrowheads). BrdU+ basal cells (arrows) in sham and olfactory bulbectomized (OBX)
mice treated with empty liposomes (Lip-O; A, C) compared to liposome-encapsulated
clodronate (Lip-C; B, D). Scale bar = 50 µm. (E) Statistical analysis showing the
significant decrease in BrdU+ basal cells in Lip-C sham and OBX mice compared to LipO mice. *** p<0.005 Lip-C vs. Lip-O; † p<0.05 OBX vs. sham.
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(4) selective macrophage depletion significantly decreased the mOSN population of the
unperturbed OE of sham OBX mice and of the OE at 48 hr after OBX; and (5) selective
macrophage depletion significantly decreased the numbers of proliferating basal cells in
the unperturbed OE of sham OBX mice and in the OE at 48 hr after OBX. These results
provide novel evidence for a neuroprotective role for resident and infiltrating OE
macrophages on OSNs in the unperturbed and target-ablated OE by regulating OSN
survival, and for a role in promoting basal cell proliferation in both conditions as well.
Macrophage Recruitment and Cellular Changes as a Result of Clodronate-Induced
Macrophage Depletion in the OE
Our results demonstrated that i.n. and i.v. administration of liposome-encapsulated
clodronate significantly decreased the number of resident OE macrophages in sham mice.
Following OBX, there was an approximate 3-fold increase in the number of CD68+ cells
in Lip-O and Lip-C mice compared to shams. The relative amount of macrophage
depletion in the Lip-C compared to Lip-O mice was maintained at 48 hr following OBX.
This suggests that OE-resident macrophages activated by OBX are a major source of
chemokines that recruit additional macrophages into the OE following OBX. This is
consistent with previous findings demonstrating that resident OE macrophages are
sources of MIP-1α and MCP-1 that recruit additional macrophages into the OE following
OBX (Nan et al., 2001; Getchell et al., 2002c; Kwong et al., 2004).
The significant decrease in OE thickness seen in the Lip-C compared to the Lip-O
mice in both the unperturbed OE and at 48 hr post-OBX suggests a number of potential
cellular changes induced by macrophage depletion. We demonstrated that basal cell
proliferation was decreased by 7.6 fold in the Lip-C sham mice compared to the Lip-O
sham mice; however, in the absence of substantial apoptosis in either group of sham
mice, it is unlikely that the decrease in proliferation over the 3 days of Lip-C treatment
could account for the observed decrease in OE thickness. Since the number of mOSNs
was decreased by 1.2 fold in the Lip-C sham mice compared to the Lip-O sham mice, it is
possible that depletion of resident macrophages had a dampening effect on either the
generation or maturation of immature (i) OSNs, which differentiate to become mature
OSNs (see Figure 2.6). The plausibility of this mechanism is supported by previous
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Figure 2.6. Proposed mechanism of increased olfactory sensory neuron (OSN) apoptosis
and decreased basal cell proliferation induced by macrophage depletion. Following
olfactory bulbectomy (OBX) in control empty liposome-treated (Lip-O) mice, resident
macrophages (MΦ) receive activation factors from apoptotic OSNs, become activated,
and secrete growth factors that prevent or delay apoptosis in the remaining mature OSN
(mOSN) and potentially immature OSN (iOSN) population, in addition to cytokines and
chemokines that recruit additional macrophages into the olfactory epithelium (OE).
Recruited macrophages secrete neuropoietic cytokines such as leukemia inhibitory factor
(LIF) that induce globose basal cell (GBC) proliferation, and thus reconstitution of the
OSN population. Following OBX in liposome-encapsulated clodronate-treated (Lip-C)
mice, there are fewer resident macrophages in the OE, and thus fewer growth factors to
prevent or delay OSN apoptosis, and fewer chemoattractants to recruit additional
macrophages into the OE. This diminished recruitment results in less basal cell
proliferation, and a longer time required to reconstitute the OSN population.
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studies demonstrating that the macrophage-derived growth factor TGF-β promotes the
maturation of mOSNs from iOSNs (Mahanthappa and Schwarting, 1993; Newman et al.,
2000; Schwob, 2002) and that iOSNs express the ligand-binding subunit of the TGF-β
receptor (Getchell et al., 2002a). At 48 hr after OBX, the significantly greater decrease in
OE thickness in Lip-C compared to Lip-O mice may be due to the combined effect of the
significantly increased OBX-induced OSN apoptosis and the significantly reduced OBXinduced basal cell proliferation in the Lip-C OBX mice, both of which contributed to the
1.9 fold decrease in the number of mOSNs in the OE of Lip-C OBX mice compared to
Lip-O OBX mice.
Increased Neuronal Death Associated with Macrophage Depletion
At 48 hr following OBX, macrophage depletion in the OE resulted in an increase in
active caspase-3 immunoreactivity and a decrease in OMP immunoreactivity, indicating
increased neuronal apoptosis and decreased numbers of mOSNs, respectively. Within the
remaining mOSN population expressing OMP in the Lip-C mice, many appeared
apoptotic. One possible mechanism responsible for these results is a lack of scavenging
of the apoptotic mOSNs following OBX due to a reduced number of macrophages in the
OE of Lip-C compared to Lip-O OBX mice. However, there was more cellular OMP
staining in the Lip-O compared to Lip-C OBX mice, indicating that a larger proportion of
the mOSN population had yet to undergo apoptosis, and thus remained viable in the LipO compared to Lip-C mice. This result suggests that the difference in apoptosis between
the Lip-O and Lip-C OBX mice may have been a direct result of macrophage depletion
on mOSN survival and not solely a lack of scavenging of apoptotic mOSNs by
macrophages.
Another possible mechanism for the increased relative active caspase-3
immunoreactivity observed in Lip-C compared to Lip-O OBX mice is a decrease in
macrophage-mediated survival in cell types other than mOSNs following OBX, including
basal cells and iOSNs. These other cell types in the OSN lineage have been shown to
undergo apoptosis following OBX, albeit in much smaller proportions compared to
mOSNs (Calof et al., 1996). There were active caspase-3+ cells and apoptotic bodies in
these OE layers, although fewer than in the mOSN cell layer. Therefore, apoptotic basal
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cells and iOSNs may contribute to the difference in relative active caspase-3 in the Lip-C
mice following OBX. Since these results were seen only after OBX, this macrophagemediated neuroprotective mechanism most likely would occur during periods of stress to
the OE in order to increase the cell turnover rate of the OSN lineage, thus maintaining a
relatively constant number of mOSNs.
In addition, since there was minimal active caspase-3 staining in the OE of Lip-C
sham mice, and co-localization with CD68 and bisbenzimide revealed very few
macrophages associated with apoptotic bodies, it is reasonable to assume that apoptosis
of macrophages via clodronate administration contributed minimally to the difference in
relative active caspase-3 immunoreactivity between Lip-O and Lip-C OBX mice. The
small number of macrophages associated with apoptotic bodies seen in both treatments
following OBX were most likely scavengers of apoptotic OSNs. Also, SCs have been
reported to possess phagocytic capabilities following OBX (Suzuki et al., 1996).
Therefore, one cannot completely rule out the possibility of a direct effect of Lip-C on
SCs. However, there was no significant difference in relative active caspase-3
immunoreactivity between Lip-O and Lip-C sham mice, and the active caspase-3
immunoreactivity and apoptotic bodies present in the OE of Lip-C OBX mice were
observed primarily in the OSN layer and not in the SC layer.
Due to the significant increase in apoptosis in the OE of Lip-C mice compared to LipO mice following OBX, one cannot completely rule out the possibility of increased
susceptibility of OSNs to direct effects of liposome-encapsulated clodronate. However,
several studies utilizing liposome-encapsulated clodronate to investigate the role of
macrophages in neuronal injury suggested that liposome-encapsulated clodronate did not
have a direct toxic effect on cell types other than macrophages. For example,
myelination, axon recovery and regeneration, and neuronal survival was enhanced
following neuronal injury in macrophage-depleted animals, with no evidence for direct
neuronal toxicity of liposome-encapsulated clodronate (Brück et al., 1996; Popovich et
al., 1999; Liu et al., 2000). Also, a study of clodronate-induced macrophage depletion in
the anterior chamber of the rat eye reported survival of endothelial cells that would
normally die during capillary regression (Diez and Lang, 1997). Therefore, it is
reasonable to conclude that the significant increase in apoptosis in the OE of Lip-C
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compared to Lip-O OBX mice is most likely a direct result of a loss of neuroprotection
provided by macrophages to mOSNs.
Macrophages May be an Additional Source of Neurotrophins
A number of studies suggested that OSNs and basal cells receive extrinsic
neurotrophic signals that regulate proliferation and OSN survival from the olfactory bulb,
mOSNs, and olfactory ensheathing cells (Harding et al., 1977; Costanzo and Graziadei,
1983; Schwob et al., 1992; Calof et al., 1998; Calof et al., 2002). Our results provide
evidence that macrophages may be an additional source for these extrinsic neurotrophicmediated effects on neuronal survival. Macrophages are known to secrete an array of
neurotrophic growth factors, including brain-derived neurotrophic factor (BDNF) and
neurotrophin-3 (NT-3; Barouch et al., 2001). Along with BDNF and NT-3, which have
been shown to inhibit apoptosis of OSNs and their precursors in vitro (Holcomb et al.,
1995), several other neurotrophic molecules secreted by macrophages, and their
receptors, have been demonstrated in the OE and/or are differentially regulated following
OBX, including epidermal growth factor (EGF), TGF- β, glial-cell line derived
neurotrophic factor (GDNF), nerve growth factor (NGF), retinoic acid (RA), and ciliary
neurotrophic factor (CNTF; Schwob et al., 1992; Getchell et al., 1996; Rawson et al.,
1996; Uramoto et al., 1998; Miwa et al., 1998; Woodhall et al., 2001; Calof et al., 2002;
Lipson et al., 2003; Simpson et al., 2003; Vigers et al., 2003; Langenhan et al., 2005;
Rawson and LaMantia, 2006). It is possible that macrophages secrete one or more of
these neurotrophic molecules in the OE to prevent and/or delay mOSN apoptosis in the
event of stress, such as axonal transection or the presence of inhaled toxins or pathogens,
or to prolong the lifespan of mOSNs under normal conditions.
Macrophage Regulation of Basal Cell Proliferation
Our results suggest that macrophages regulate basal cell proliferation in the
unperturbed OE and at 48 hr after OBX. In sham Lip-O mice, there was a greater
number of proliferative basal cells (about 2.5/0.25 mm) than have been previously
reported in the OE of barrier-housed mice. For example, in the contralateral OE of
unilateral OBX mice, an average of 1.5 proliferative basal cells/0.25 mm of septal OE
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were present at 48 hr after OBX (Schwartz Levey et al., 1991; Nan et al., 2001). Because
macrophages phagocytose liposomes (van Rooijen and van Kesteren-Hendrikx, 2002),
phagocytosis activates macrophages (Fadok and Chimini, 2001), and macrophages
produce growth factors that promote basal cell proliferation in the OE (Nan et al., 2001;
Getchell et al., 2002b), it is possible that the up-regulation of basal cell proliferation in
the unpertubed OE of Lip-O sham mice resulted from the activation of resident OE
macrophages to secrete growth factors upon phagocytosis of the empty liposomes.
The number of proliferative basal cells in the Lip-O OBX mice was not significantly
different from those in the Lip-O shams not because OBX failed to increase the number
but because the number was elevated in the Lip-O sham mice. In the Lip-O OBX mice,
the average of about 2.4 proliferative basal cells/0.25 mm OE is not very different from
the 1.25 proliferative basal cells/0.25 mm OE on the ipsilateral side of unilateral OBX
mice (Schwartz Levey et al., 1991) to 2.0 proliferative basal cells/0.25 mm OE of
bilateral OBX mice (Nan et al., 2001). Basal cell proliferation significantly increased in
the Lip-C OBX mice compared to Lip-C shams, which was commensurate with the
significant increase in the number of CD68+ macrophages in the OE of Lip-C mice at 48
hr following OBX. Several neuropoietic cytokines and their receptors are differentially
regulated following OBX, most notably leukemia inhibitory factor (LIF; Nan et al., 2001;
Getchell et al., 2002b; Bauer et al., 2003). In addition, LIF knockout mice exhibit
reduced basal cell proliferation (Kim et al., 2005). Therefore, basal cell proliferation may
be regulated through the secretion from macrophages of one or more cytokines with
neuropoietic functions.
Proposed Mechanism of Macrophage-Mediated Neuroprotection in the OE
A major advantage of utilizing the olfactory system in studying the mechanisms
underlying neuronal death and replacement through proliferation, differentiation, and
maturation is that these events can be synchronized by performing OBX. This technique
induces apoptosis in nearly all mOSNs over a period of several days (Harding et al.,
1977; Costanzo and Graziadei, 1983; Schwob et al., 1992). Therefore, since OBX
induces apoptosis in approximately the same number of mOSNs in both Lip-O and Lip-C
treatments, one possible mechanism that may be responsible for the increase in the
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amount of relative active caspase-3 immunoreactivity in the Lip-C OBX mice is a shift in
temporal events leading to mOSN apoptosis. This would result in mOSN apoptosis
occurring at earlier time points following OBX in the Lip-C mice compared to Lip-O
mice.
Our proposed model (Figure 2.6) suggests that following OBX, several OSNs,
primarily mOSNs, undergo apoptosis immediately. These apoptotic neurons send
activation signals, which may include IL-1β (Getchell et al., 2006), to resident
macrophages, which respond by secreting survival factors, such as neurotrophins and/or
growth factors, that act upon the OSNs that have yet to undergo apoptosis. These
survival factors may then delay the rate of apoptosis in the remaining OSN population.
The activated macrophages also secrete chemokines, such as MCP-1 and MIP-1α
(Getchell et al., 2002c; Kwong et al., 2004), which recruit additional macrophages into
the OE. These additional macrophages secrete neuropoietic cytokines, such as LIF (Nan
et al., 2001), that induce basal cell proliferation, replenishing the OSN lineage. In
macrophage-depleted Lip-C mice, these signaling mechanisms are diminished, resulting
in more rapid apoptosis and slower replenishment of the OSN lineage. This would
indicate that in normal mice, under conditions of stress, macrophages prevent or delay
mOSN apoptosis to allow time for the basal cells and iOSNs to replace the mOSNs and
maintain neuronal function. This would also suggest that macrophages prolong the
lifespan of mOSNs and regulate neuronal turnover in the OE under normal conditions.
Our model of macrophage-mediated neuroprotection in the OE is supported by
previous studies of olfactory sensory neurogenesis in 2 transgenic mouse models in
which genes modulating macrophage function were disrupted. In both Mip-1α knockout
mice and mice with disruption of the gene encoding scavenger receptor A, macrophage
infiltration into the OE, OE thickness, and basal cell proliferation were significantly
reduced following OBX compared to wild type mice (Kwong et al., 2004; Getchell et al.,
2006). One major difference between our clodronate-induced macrophage depletion
model and the transgenic models is that the latter showed no significant decrease in the
number of macrophages in the OE, thickness of the OE, and basal cell proliferation in
sham transgenic mice versus wild type mice. In our clodronate model, macrophage
depletion was associated with a significant decrease in OE thickness, numbers of
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mOSNs, and basal cell proliferation in both sham mice and at 48 hr following OBX.
Taken together, our data indicate the direct participation of macrophages in the
mechanisms regulating neuronal survival and neurogenesis in the unperturbed OE and in
the OE following OBX.

Conclusions and Future Studies
The results presented in this paper provide evidence for the role of macrophages in
olfactory sensory neurogenesis. Administration of liposome-encapsulated clodronate
effectively reduced the number of macrophages in the OE. Macrophage depletion
resulted in a decrease in OE thickness, the number of mOSNs, and basal cell
proliferation; and an increase in OSN apoptosis following OBX. Future studies will
focus on determining which bioactive molecules secreted by macrophages are involved in
the regulation of these neurogenic mechanisms. In addition, temporal studies will be
performed to determine if macrophage depletion induces a shift in the time course of
cellular and molecular mechanisms leading to degeneration and reconstitution of the
mOSN population following OBX. Overall, our results provide a framework for
characterizing the mechanisms involved in macrophage regulation of OSN survival and
turnover.
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CHAPTER THREE

Macrophage-Mediated Neurodegeneration, Neuroprotection, and Neurogenesis in
the Olfactory Epithelium

Note: Chapter Three consists of a first-author submitted manuscript (Borders et al.,
2007b). In the Results section of Chapter Three, I, Aaron Borders, contributed 100% to
the research shown in Figures 3.8, 3.9, and 3.10; 75% to the research shown in Figures
3.6, 3.7, and 3.11; and 50% to the research shown in Figures 3.1, 3.2, 3.3, 3.4, and 3.5.

45

Introduction
The dynamic environment of the olfactory epithelium (OE), where olfactory
sensory neurons (OSNs) undergo apoptosis and are replaced by basal progenitor cells
throughout life (Calof et al., 1996; Monti Graziadei and Graziadei, 1979; Schwob, 2002),
is continually providing insights into the mechanisms of neuroprotection, neuronal
apoptosis, and neurogenesis. More specifically, recent studies (Borders et al., 2006;
Getchell et al., 2006; Kwong et al., 2004) on the interaction between the immune system
and the unique mechanism of neurogenesis in the OE have strengthened the case for the
macrophage-mediated regulation of OSN survival and the proliferation, differentiation,
and maturation of OSN progenitors in the unperturbed OE and during OE remodeling as
a result of olfactory bulbectomy (OBX)-induced OSN apoptosis.
The OE contains the somas of immature and mature OSNs (iOSNs and mOSNs,
respectively), whose axons project to the olfactory bulb (OB) through nerve bundles in
the underlying stroma (Mombaerts, 2006). OBX removes the synaptic targets of mOSNs
and severs their axons, inducing their synchronous retrograde apoptosis via activation of
the caspase pathway (Carson et al., 2005; Cowan et al., 2001). The apoptotic mOSNs are
phagocytosed by macrophages (Suzuki et al., 1995) that secrete chemokines, including
macrophage inflammatory protein-1α (MIP-1α) and monocyte chemoattractant protein-1
(MCP-1), to recruit additional macrophages into the OE (Getchell et al., 2002c; Kwong et
al., 2004). Furthermore, OBX-induced OSN apoptosis results in an increase in mitotic
activity of basal cells in the OE, some of which differentiate to become new OSNs (Calof
et al., 2002; Camara and Harding, 1984; Carter et al., 2004; Schwartz Levey et al., 1991).
The temporal increase in basal cell proliferation following OBX has been reported to
coincide with the infiltration of macrophages into the OE (Nan et al., 2001).
Macrophages are diverse immune effector cells that possess the capabilities to
perform an array of functions pertaining to their environment, especially in cases of
damage to the nervous system (Gordon and Taylor, 2005; Perry et al., 1993; Schwartz
and Yoles, 2006). In addition to their phagocytic capacity, macrophages secrete a
number of molecules that perform neuropoietic functions in the nervous system
(Szelenyi, 2001), including the OE. For example, OBX induced an increase in the levels
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of expression of two neuropoietic cytokines, leukemia inhibitory factor (LIF) and
interleukin-6 (IL-6), and their receptors (LIFR and IL6R, respectively) (Getchell et al.,
2005; Getchell et al., 2002b; Nan et al., 2001). LIF was expressed by macrophages and
OSNs; LIFR was expressed by globose basal cells (GBCs) and olfactory ensheathing
cells (OECs); and IL6R was expressed by OECs. LIF has also been demonstrated to
promote basal cell proliferation in vivo and in vitro (Bauer et al., 2003; Kim et al., 2005).
Additionally, growth factors that are secreted by macrophages (Nathan, 1987) have been
implicated in regulating basal cell proliferation and differentiation as well as OSN
survival. These growth factors include; for example, members of the fibroblast growth
factor (FGF), transforming growth factor-α and β (TGF-α, TGF-β), insulin-like growth
factor (IGF), and platelet-derived growth factor (PDGF) families (reviewed in (Kawauchi
et al., 2004; Mackay-Sim and Chuah, 2000; Schwob, 2002)), thus supporting the
evidence for macrophage-mediated neurogenesis in the OE.
We previously introduced the use of the macrophage apoptosis-inducing agent
liposome-encapsulated clodronate to selectively deplete resident and recruited
macrophages in the OE (Borders et al., 2006). Analogous to OBX, where mOSNs are
selectively depleted through induced retrograde apoptosis, intranasal administration of
liposome-encapsulated clodronate selectively depletes macrophages in the nasal mucosa.
Liposome-encapsulated clodronate is phagocytosed by macrophages. The phospholipid
bilayer of the liposome is then broken down by the macrophage’s phospholipases,
resulting in the release of free clodronate molecules inside the cell, which induces
apoptosis in the macrophage (Van Rooijen and Sanders, 1994). Studies utilizing
liposome-encapsulated clodronate-induced macrophage depletion have defined tissue
protective/remodeling roles of macrophages in experimental models ranging from retinal
vasculogenesis (Checchin et al., 2006) and CNS remyelination (Kotter et al., 2005) to
suppression of experimental colitis (Qualls et al., 2006).
We demonstrated that intranasal and intravenous administration of the selective
macrophage depletion agent liposome-encapsulated clodronate induced a significant 38%
and 35% reduction in resident and recruited macrophages in the OE of sham and 48 h
OBX mice, respectively (Borders et al., 2006). Macrophage depletion in the OE resulted
in a decrease in OE thickness and the number of OMP+ mOSNs and BrdU+ proliferating
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basal cells in sham and 48 h OBX mice. Additionally, using immunohistochemical
detection of activated caspase-3, we demonstrated that macrophage depletion in the OE
led to an increase in apoptosis of OSNs at 48 h following OBX. However, the molecular
mechanisms that underlie this macrophage-mediated neuroprotection and neurogenesis in
the OE are not completely understood.
The aim of this study was to identify the macrophage-mediated molecular
mechanisms that regulate OSN survival, and the proliferation and differentiation of OSN
progenitors. We used a microarray pattern analysis to analyze differential gene
expression levels in the OE of sham and OBX liposome-encapsulated clodronate-treated
mice compared to empty liposome-treated mice, coupled with molecular validation of
selected genes and cellular validation of selected gene products in the OE.

Materials and Methods
Animals
Twenty-four 6-week old C57BL/6J male mice obtained from Jackson Labs (Bar
Harbor, Maine) were maintained on a 12:12 h light:dark cycle in the Department of
Laboratory Animal Research facilities and were given food and water ad libitum. All
protocols were implemented in accordance with the NIH guidelines and approved by the
University of Kentucky Institutional Animal Care and Use Committee.
Macrophage Depletion
Liposome-encapsulated clodronate was used to deplete both resident OE
macrophages and blood monocytes, which are recruited into the OE following OBX.
Liposomes were prepared as previously described (Van Rooijen and Sanders, 1994).
Clodronate was a gift from Roche Diagnostics Gmbh, Mannheim, Germany.
Overlapping series of injections were administered locally and systemically (Table 3.1)
as previously described (Borders et al., 2006). To deplete OE macrophages, 12 mice
were anesthetized with isoflurane and injected intranasally (i.n.) with 50 µl of liposomes
containing clodronate (Lip-C) once per day at 4 PM for three consecutive days. To
deplete a subpopulation of blood monocytes (Sunderkotter et al., 2004), the mice were
injected intravenously (i.v.) with 200 µl Lip-C in the lateral tail vein on the first and third
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days of i.n. injections at the same time of day. As controls, the remaining 12 mice were
injected with empty liposomes without clodronate (Lip-O) in the same manner and on the
same schedule as Lip-C mice.
Olfactory Bulbectomy (OBX)
Six mice per group (Lip-O, Lip-C; n=12) underwent OBX as described previously
(Getchell et al., 2005) on the second day of the injection series (Table 3.1). Mice were
anesthetized with Avertin (2,2,2-tribromoethanol and tert-amyl alcohol; Aldrich
Chemical Co., St. Louis, MO; 300 mg/kg i.p.), and bilateral OBX was performed using
vacuum aspiration with a glass pipette. The resulting cavity was filled with sterile
Gelfoam. Incisions were sutured, followed by application of a topical antiseptic
(Betadine). The remaining six mice per group (n=12) underwent bilateral sham OBX as
previously described (Getchell et al., 2005).
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Table 3.1. Experimental schedule.
Treatment
Lip-O
(n=12)

Injection
Route/Surgery

Injection Volumes and Procedures
Day 1
Day 2
Day 3
Day 4

i.n.

50 μl

50 μl

50 μl

i.v.

200 μl

0 μl

200 μl

Surgery
Lip-C
(n=12)

Euthanize

Sham or OBX

i.n.

50 μl

50 μl

50 μl

i.v.

200 μl

0 μl

200 μl

Surgery

Euthanize

Sham or OBX

Volumes and days of injections, along with days of surgery and tissue harvesting. Six
mice from each treatment underwent either sham or OBX. Abbreviations: Lip-O, empty
liposomes; Lip-C, liposomes containing clodronate; i.n., intranasal; i.v., intravenous;
OBX, olfactory bulbectomy. Modified from (Borders et al., 2007).
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Tissue Harvesting
Mice that were used for microarray and real-time RT-PCR analysis (n=12; 3 per
group/surgery) were euthanized by CO2 asphyxiation 48 h following either bilateral sham
OBX or OBX surgery. Olfactory nasal mucosae, lungs, spleens, and brains were rapidly
microdissected using RNase-free techniques, weighed, flash-frozen in liquid N2, and
stored at -80°C. Mice that were used for histological and immunohistochemical studies
(n=12; 3 per group/surgery) were injected with 5-bromo-2’-deoxyuridine (BrdU; SigmaAldrich Inc., St. Louis, MO; 100 mg/kg i.p.) in sterile saline 2 h prior to euthanization.
Mice were euthanized with an overdose of sodium pentobarbital (Butler Company,
Columbus, OH; 0.3 cc i.p.) at 48 h following either bilateral sham OBX or OBX and
perfused transcardially with chilled sterile 0.1M PBS (pH 7.4) followed by chilled 3%
paraformaldehyde (PFA). Olfactory nasal mucosae, lungs, spleens, and guts were
collected and placed in 3% PFA on ice for 2 h, and were cryoprotected in 15-30%
sucrose in PBS. The following day, tissues were placed in fresh 30% sucrose for 1 h,
then embedded in OCT and sectioned at 12 µm. Sections were mounted on Superfrost
Plus microscope slides (Fisher Scientific, Pittsburg, PA).
All reagents used in animal preparation and tissue collection were molecular
biology grade. Surgical instruments and disposables were RNase-free, and surgery and
tissue collection were performed using RNase-free techniques.
RNA Isolation
Total RNA was isolated from the olfactory mucosa of each mouse under RNasefree conditions as previously described (Getchell et al., 2006; Kwong et al., 2004).
Tissues were homogenized using 1 ml of TRI Reagent (Molecular Research Center Inc.,
Cincinnati, OH) and processed through a Qiashredder at maximum speed for 1 min.
Total RNA was further extracted and purified using the Qiagen RNeasy Mini-Kit (Qiagen
Inc., Valencia, CA) according to the manufacturer’s protocol. The yield and purity of
each total RNA sample was analyzed spectrophotometrically (DU 640
Spectrophotometer, Beckman Coulter, Fullerton, CA) and with a 2100 Bioanalyzer
(Agilent Technologies, Palo Alto, CA). All samples had A260/A280 ratios greater than 2.0
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and had two sharp peaks corresponding to 18S and 28S RNA on Bioanalyzer
electropherograms.
High-Density Oligonucleotide Arrays
Microarray analysis using Affymetrix Murine Genome (MG) U430 2.0
GeneChips (Affymetrix, Santa Clara, CA) was performed in the University of Kentucky
Microarray Core Facility to determine the expression levels of all probe sets in the mouse
genome. The microarray dataset was deposited into the Gene Expression Omnibus
(GEO) database; the accession number is GSE6540. Twelve GeneChips were used: 3
each for Lip-O sham, Lip-O OBX, Lip-C sham, and Lip-C OBX mice. Each GeneChip
was hybridized with unpooled total RNA isolated from the olfactory mucosa of a single
mouse. Hybridization of unpooled RNA, normalization, and signal acquisition were
performed as previously described according to the Affymetrix protocol (Getchell et al.,
2006; Kwong et al., 2004). Each GeneChip contained 45,101 probe sets, including 64
quality control probe sets, 17,373 expressed sequence tags (ESTs) and non-annotated
probe sets, and 27,664 annotated probe sets (Figure 3.1). The hybridization signals were
normalized across all chips and analyzed using Affymetrix Microarray Suite Version 5
(MAS5). Each normalized hybridization signal was assigned an “Absolute Call” by
MAS5. Based on the Absolute Call analysis, the hybridization signal for each probe set
was designated as Present, Marginal, or Absent. The probe sets that were identified as
Absent on every chip as well as ESTs and non-annotated probe sets were not included in
the statistical analysis.
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Figure 3.1. Flowchart depicting statistical analysis of microarray data to identify genes
with significant interaction and main effects. Probe sets and statistical tests used in the
analysis are in bold.
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Statistical Analysis of Microarray Data
To determine which of the annotated probe sets were significantly regulated by
Lip-C, OBX, or both, the mean hybridization signals were analyzed using a 2X2 analysis
of variance (ANOVA) assuming equal variance, with group (Lip-O, Lip-C) as one factor
and treatment (sham, OBX) as the other factor. The overall significant (p<0.01) probe
sets were further analyzed by pairwise comparisons to characterize the probe sets as
either: 1) interaction effect genes, defined as having a statistically significant interaction
(p<0.01) between group and treatment; 2) main effect genes, defined as having a
statistically significant difference (p<0.01) between groups, treatments, or both, with no
significant interaction (p≥0.01); or 3) genes that did not have a statistically significant
pairwise effect (p>0.01). The fold changes of the expression levels are calculated as the
mean hybridization signals of Lip-C versus Lip-O for group and OBX versus sham for
treatment. Data were analyzed using SAS (SAS Institute, Cary, NC) and SigmaPlot
(SPSS, Chicago, IL).
Categorical Analysis
Expression Analysis Systematic Explorer (EASE) was used to identify overrepresented functional gene categories within the interaction and main effect genes.
Interaction, up- and down-regulated main effect group, and up- and down-regulated main
effect treatment genes were analyzed separately against the genes that were overall
significantly regulated (p<0.01). There were no over-represented categories among the
overall significant genes that did not have a significant pairwise effect. EASE uses the
upper-bound Fisher’s Exact Test to determine significance of a defined functional gene
category (Hosack et al., 2003). The gene categories with an EASE score < 0.05 were
considered to be over-represented (Getchell et al., 2006; Liu et al., 2005). For simplicity,
categories that share functional characteristics were grouped into broadly defined
categories. Gene Ontology (GO) Biological Process, Cellular Component, and Molecular
Function annotations were used to categorize genes.
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Real-time RT-PCR (qPCR)
qPCR was performed to validate the microarray expression patterns of seven
selected genes using the ABI Prism 7000 Sequence Detection System (Applied
Biosystems, Foster City, CA) in the Sanders-Brown Center on Aging at the University of
Kentucky. Reactions were run using cDNA that was reverse-transcribed from the
unpooled RNA samples used for microarray analysis. Reverse transcription was
performed by combining 1 μg of total RNA with the GeneAmp RNA PCR Core Kit
(Applied Biosystems) for each sample (n=12). Samples without reverse transcriptase
were run to ensure that there was no DNA contamination. The qPCR reactions were run
using Power Sybr® Green PCR Master Mix (Applied Biosystems). Each well contained
12.5 μl of Master Mix, 10.5 μl RNase-free H2O (Invitrogen, Eugene, OR), 0.5 μl forward
primer (15 μM), 0.5 μl reverse primer (15 μM), and 1 μl unpooled sample cDNA (10 ng).
Three or four serially diluted standards were run in duplicate for each target amplicon in
a similar manner as the samples. No-template controls were run in duplicate using 25 μl
of Master Mix without cDNA to confirm the absence of nonspecific amplification and
primer-dimer formation. Primer sequences obtained either from the literature or designed
using Primer Express (Applied Biosystems) were purchased from Invitrogen. Table 3.2
lists the primer sequences, Ta (annealing temperature of primers), expected amplicon size
(bp), Tm (melting temperature of amplicon), and primer sequence reference for each
qPCR validation target amplicon. The reaction parameters were as follows: 2 min at
50°C; 15 min at 95°C; and 40 cycles of 15 s at 94°C, 30 s at the appropriate annealing
temperature for each primer (Table 3.2), and 1 min at 72°C. All 12 samples were run in
triplicate. A dissociation curve was run at the end of each reaction to verify the presence
of a single amplicon with the appropriate melting temperature. Additionally, a 2%
agarose gel stained with 1X Sybr® Green I in dH2O (Invitrogen) was run to verify the
presence of a single amplicon of the correct size. Samples without reverse transcriptase
had no amplification after 40 cycles, confirming no DNA contamination of the cDNA
samples.
ABI Prism 7000 SDS Software (Applied Biosystems) was used to calculate the
mean quantity (ng) of cDNA in each sample by comparing the comparative threshold
cycle (CT) of each sample to the standard curve for each gene. A linear regression curve
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Table 3.2. Primers used for real-time RT-PCR validation.
Target

Sequence

Interaction Genes
F: 5'-CCCCAGCAAAAGGAGAAGCT-3'
Ccnd2
R: 5'-GCGGGTACATGGCAAACTTG-3'
F: 5'-AACCCCAACAGATGTCCGTCT-3'
Socs5
R: 5'-TCTGCGGCACAGTTTTGGT-3'
F: 5'-AAGAAGGTCACGCAACTGGATC-3'
Pdap1
R: 5'-TGTTTCCGGATGATTGCCA-3'
Neurod1 F: 5'-ACAGACGCTCTGCAAAGGTTTG-3'
R: 5'-GCGGATGGTTCGTGTTTGAAAG-3'

Ta (°C)

Size (bp)

Tm (°C)

Reference

50

94

81

Diederichs et al., 2005

50

158

82

Takase et al., 2005

50

167

81

Primer Express

50

366

88

Chen et al., 2002
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Main Effect Genes
F: 5'-GACATTCTTCTAGCTGCTCC-3'
50
348
85
Buiakova et al., 1994
Omp
R: 5'-CAGCTTTGGCCAGCAGGG-3'
50
266
85
Primer Express
Crabp1 F: 5'-TGAACGCCATGCTGAGGAA-3'
R: 5'-CATCCCCCTCAAGAAGTGTCTG-3'
50
525
85
Tran et al., 2004
F: 5'-GGTCTGGAGACTATGACTCC-3'
Cxcr4
R: 5'-CACAGATGTACCTGTCATCC-3'
Abbreviations: Ccnd2, cyclin D2; Socs5, suppressor of cytokine signaling 5; Pdap1, PDGFA associated protein 1; Neurod1,
neurogenic differentiation 1; Omp, olfactory marker protein; Crabp1, cellular retinoic acid binding protein 1; Cxcr4, chemokine (C-XC motif) receptor 4; F, forward primer; R, reverse primer; Ta, primer annealing temperature; Tm, amplicon melting temperature.

was fitted to the CT of the standards for each gene to calculate the mean quantity for each
sample. All standard curves had a R2 ≥ 0.97. The CT for dilution 1 of Omp was
extrapolated from the linear regression curve equation for comparison with the other six
genes. The mean quantities for each reaction product in triplicate were averaged per
mouse and the significance calculated using a 2X2 ANOVA assuming equal variance,
with group as one factor and treatment as the other factor, similar to the microarray
statistical analysis.
Immunohistochemistry
Immunohistochemistry was performed to validate the microarray expression
patterns of the product of Hdgf, and to localize it in the OE. For the nuclear antigen
HDGF (hepatoma-derived growth factor), sections were rehydrated using PBS, pretreated
with 2.5% preheated trypsin (37°C) for 2 min, followed by three 5-min rinses in PBS.
Slides used for HDGF localization were then incubated in 2N HCl at 37°C for 40 min
followed by two 5-min rinses in borate buffer (pH 7.4) and three 5-min rinses in PBS. To
compare the distribution of SDF-1 (also known as CXCL12), the ligand for CXCR4, and
CD68+ macrophages, adjacent sections were rehydrated using PBS without pretreatment.
All sections were incubated in a blocking solution (2% BSA with 0.4% Triton X100 in PBS for SDF-1 and CD68; 1% BSA with 0.5% Tween20 in PBS for HDGF) for
30 min at room temperature and then in either the blocking solution alone or the primary
antibody(s) diluted in the blocking solution overnight at 4°C. To test the specificity of
the HDGF antibody, a blocking peptide (Santa Cruz Biotech, Santa Cruz, CA) was
incubated with the primary antibody overnight at 4°C at a concentration of 1:10
antibody:peptide, followed by centrifugation for 15 min. The blocking peptide solution
supernatant was incubated on the tissue section in the blocking solution overnight at 4°C
as with the primary antibodies.
SDF-1 and HDGF immunoreactivity were visualized with a Rhodamine red X
(RRX)-conjugated donkey anti-goat IgG secondary antibody (Jackson Immunoresearch,
West Grove, PA) used at a dilution of 1:150. CD68 immunoreactivity was visualized
with a RRX-conjugated donkey anti-rat IgG secondary antibody (1:150; Jackson
Immunoresearch). Sections were incubated with the secondary antibodies for 1 h at room
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temperature in the dark. Sections that were incubated with the blocking solution alone or
with the blocking peptide supernatant showed no specific staining. Additionally, control
tissues were used to compare immunoreactivity for each antibody to published data.
Table 3.3 lists the source, immunogen, host, preparation, and optimal dilution for each
primary antibody. Images were minimally edited digitally using Adobe Photoshop CS2
V9.0 (Adobe Systems) to increase brightness and contrast.
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Table 3.3. Primary antibodies for immunohistochemistry.
Primary
Antibody
SDF-1
CD68

HDGF

Source

Immunogen

Preparation Host

Santa Cruz Biotec,
Santa Cruz, CA (sc6193)
Serotec, Raleigh, NC
(MCA 1957 GA)

Generated from a peptide corresponding to the Cterminus of SDF-1 of human origin

Polyclonal

Produced by a hybridoma line (FA/11) generated by the Monoclonal
fusion of spleen cells from a mouse immunized with
purified ConA acceptor glycoproteins from the P815
cell line.
Generated from a peptide corresponding to the NPolyclonal
terminus of HDGF of human origin

Dilution

Gt

1:250

Rt

1:100
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Santa Cruz Biotec,
Gt
1:100
Santa Cruz, CA (sc28062)
Abbreviations: Gt, goat; Rt, rat; Ms, mouse; SDF-1, stromal cell derived factor-1; HDGF, hepatoma-derived growth factor.

Results
Data Analysis and Significance Tests
The flow chart (Figure 3.1) describes the microarray analysis performed on the
mean hybridization signals to identify genes in the OE that were significantly regulated
by macrophage depletion and/or OBX. Among the 27,664 annotated probe sets, an
Absolute Call analysis identified 21,954 probe sets (79%) that were present on at least
one GeneChip. A 2X2 ANOVA identified 4,085 overall significantly regulated genes
(p<0.01, 19%) out of the 21,954 present probe sets on the Affymetrix MG U430 2.0
GeneChip (Figure 3.1). Pairwise comparisons of the 4,085 overall significantly regulated
genes identified 4,024 genes (99%) that had a significant pairwise effect (interaction or
main effect; p<0.01) and 61 genes (1%) that did not have a significant pairwise effect
(p≥0.01). Of the 4,024 genes that had a significant pairwise effect, there were 980 genes
(24%) whose mean hybridization signals had a significant interaction (p<0.01) between
group (Lip-O, Lip-C) and treatment (sham, OBX), and 3,044 genes (76%) whose mean
hybridization signals had significant main effects (p<0.01) of group (n=364, 12%),
treatment (n=2,266, 74%), or both (n=414, 14%). The 980 interaction genes are those
whose expression in the Lip-C mice had a statistically significantly different response to
OBX than in the Lip-O mice. For example, the mean hybridization signal of Hdgf, a
neuronal survival and proliferative growth factor, was not significantly different between
the Lip-O and Lip-C sham mice as determined by a two-sample t-test (p=0.2). However,
at 48 h following OBX, the expression of Hdgf increased significantly (p<0.01; 1.2-fold)
in the Lip-O mice and remained relatively unchanged in the Lip-C mice (p=0.3). The
expression of Hdgf was significantly greater in the Lip-O mice compared to the Lip-C
mice at 48 h following OBX (p<0.01; 1.2-fold).
The remaining 3,044 genes that had a significant effect were main effect genes;
that is, their response to OBX was not statistically significantly different between the LipO and Lip-C mice. Of the 3,044 main effect genes, the mean hybridization signals of 778
genes (26%) had a statistically significant difference (p<0.01) between Lip-C and Lip-O
mice (group), 414 of which also had a statistically significant difference between OBX
and sham (treatment). For example, the mean hybridization signal of Cxcr4, the receptor
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for the chemokine SDF-1 that is involved in axonogenesis and leukocyte trafficking, was
significantly greater in the Lip-O compared to the Lip-C sham mice (p<0.01; 1.2-fold).
At 48 h following OBX, the mean hybridization signal of Cxcr4 increased marginally
(0.01≤p≤0.05) in the Lip-O (1.4-fold) and Lip-C mice (1.1-fold), while the expression
level in the Lip-C mice was significantly less than in the Lip-O mice at 48 h following
OBX (p<0.01; 1.5-fold). Therefore, Cxcr4 was categorized as a main effect group and
treatment gene. Of the 778 main effect group genes, the mean hybridization signals of
432 genes (56%) were significantly greater in the Lip-C mice compared to the Lip-O
mice, while the mean hybridization signals of 346 genes (44%) were significantly lower
in the Lip-C mice compared to the Lip-O mice.
Of 3,044 main effect genes, 2,680 genes (88%) had mean hybridization signals
that were significantly different between the sham and OBX mice (treatment effect), of
which 1,347 (50%) were significantly up-regulated and 1,333 (50%) were significantly
down-regulated at 48 h following OBX. For example, the mean hybridization signal of
Omp (olfactory marker protein), a marker for mature OSNs, was not significantly
different between the Lip-O and Lip-C sham mice (p=0.1). At 48 h following OBX, the
expression of Omp in both the Lip-O and Lip-C mice was significantly down-regulated
(p<0.01; 2.4- and 1.5-fold, respectively) compared to the sham mice. However, there
was no significant difference in the expression of Omp between the Lip-O and Lip-C
mice at 48 h following OBX (p=0.06), indicating a similar response to OBX in both
groups with no Lip-C effect. Therefore, Omp was identified as a main effect treatment
gene.
These results identified 4,085 genes whose mean hybridization signals were
overall significantly regulated and 4,024 genes that were significantly regulated by LipC, OBX, or both. The expression levels of these genes displayed a variety of patterns,
providing evidence for diverse functional roles in the OE among these significantly
regulated genes.
Categorical Analysis
EASE analysis was performed using Gene Ontology (GO) Biological Process,
Cellular Component, and Molecular Function annotations to identify functional
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biological themes within the significant interaction and main effect genes (Table 3.4).
Several categories were identified that may elucidate mechanisms responsible for the
decrease in OSN maturation, survival, and turnover that we previously reported to be
associated with macrophage depletion in the OE.
The EASE analysis of the genes with a significant interaction identified overrepresented functional gene categories within the genes that responded to OBX
differently in the Lip-C mice compared to the Lip-O mice. Within the 980 interaction
genes, there were 37 over-represented GO categories (EASE score < 0.05). Of particular
interest was the over-representation of 12 nucleic acid activity/ transcription categories
that included genes involved in the promotion and regulation of the cell cycle, e.g.,
Neurod1 (neurogenic differentiation 1) and Cdk9 (cyclin-dependent kinase 9). The five
over-represented metabolism and enzyme activity categories contained several cyclinrelated genes, including Ccnh (cyclin H) and Cdkl2 (cyclin-dependent kinase-like 2).
Additionally, apoptosis genes, e.g., Bcl2 (B-cell leukemia/lymphoma 2), were present
among the five over-represented metabolism categories. Also relevant to our hypothesis
were four over-represented cytoskeleton gene categories that consisted primarily of
kinesin family members and microtubule-associated protein genes. There were three
categories associated with a response to stimulus that included several members of the
heat shock protein family of genes and cytokine signaling, e.g., Hspa9 (heat shock
protein 9) and Socs5 (suppressor of cytokine signaling 5), respectively, providing
evidence for the differential immune response to OBX as a result of macrophage
depletion in the Lip-C mice.
The EASE analysis of the genes with a significant group main effect was of
special interest because the expression levels of these genes had a statistically significant
Lip-C effect. Of the 778 main effect group genes, the 432 genes whose mean
hybridization signals were significantly greater in Lip-C mice compared to Lip-O mice
had 23 over-represented functional gene categories. The majority of these categories
were associated with amino acid metabolism and enzymatic activity. Of special
relevance to this study based on our hypothesis was the over-represented growth factor
activity category, which included Fgf21 (fibroblast growth factor 21) and Bmp6 (bone
morphogenic protein 6).
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Table 3.4. EASE analysis of significantly regulated genes in the olfactory epithelium following macrophage depletion.
Significance

Expression
Pattern

Interaction Genes
(Group vs. Treatment)

Main Effect Genes
Up-Regulated
Group
(Lip-C vs. Lip-O)

# Probe
sets
980

# Over-represented
categories
37

432

23

GO category

Example Genes

Nucleic acid activity (12)
Metabolism (5)
Enzyme activity (5)
Protein modification (5)
Cytoskeleton (4)
Response to stimulus (3)

Neurod1, Cdk9
Ccnh, Bcl2
Cdkl2
Cdc5l, Usp12
Mtap1b, Kif6
Hspa9, Socs5
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Nucleic/amino acid activity (11)
Enzyme activity (8)
Growth factor (1)
Down-Regulated
346
14
Metabolism (4)
Immune response (3)
Nucleotide activity (3)
Cell cycle (2)
Up-Regulated
1347
35
Cytoskeleton (12)
Treatment
(OBX vs. Sham)
Membrane (8)
Enzyme activity (5)
Signaling (3)
Down-Regulated
1333
43
Transport (15)
Olfaction (8)
Ion channel activity (7)
Neurosynaptic activity (7)
The major over-represented categories for each pattern are shown along with examples of genes in each category.

Asns, Phgdh
Nars, Usp21
Fgf21, Bmp6
Sox2, Mapk8
Cxcr4, C9
Hes6, Ngn1
Cdk4
Actg1, Lamb3
Scarb1, Fgfr2
Ntrk2
Igf1, Stat6
Syt4, Vamp2
Omp, Olfr15
Cnga2
Sv2a
Functionally related

GO Biological Process, Cellular Component, and Molecular Function categories were grouped into broadly defined categories: the

number of grouped categories is in parentheses. Abbreviations: Lip-C, liposome-encapsulated clodronate; Lip-O, empty liposomes;
OBX, olfactory bulbectomy; GO, Gene Ontology.
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There were 14 over-represented functional gene categories among the 346 main
effect group genes whose mean hybridization signals were significantly lower in the LipC mice compared to Lip-O mice. Three categories were functionally associated with the
immune response, which included Cxcr4, and two categories that were associated with
the cell cycle, which included Cdk4 (cyclin-dependent kinase 4), consistent with the
depletion of macrophages in the OE and the decrease in basal cell proliferation reported
in Lip-C sham and OBX mice compared to Lip-O mice. There were also four
metabolism categories that contained genes associated with nucleotide metabolism and
transcription factor activity. For example, Sox2 (SRY-box containing gene 2), a
transcription factor involved in neuronal development and proliferation, was identified in
several metabolism categories as well as cell cycle categories.
Of the 2,680 genes with a significant treatment main effect, there were 35 overrepresented categories among the 1,347 genes that were significantly up-regulated at 48 h
following OBX compared to sham mice. These 35 categories included 12 categories
associated with the cytoskeleton and cell adhesion, consisting of genes encoding actins,
laminins, vimentins, collagens, and other cytoskeleton and extracellular matrix
molecules. There were eight over-represented categories of membrane-associated genes
that included scavenger receptor, CD antigen, G protein coupled-receptor, growth factor
receptor, and aquaporin genes. These results are consistent with the increase in OE tissue
remodeling activity occurring at 48 h following OBX.
There were 43 over-represented categories among the 1,333 main effect treatment
genes that were significantly down-regulated at 48 h following OBX compared to sham
mice. Eight of the 43 over-represented categories were olfactory-associated gene
categories, which included seven olfactory receptor genes (Olfr15, 16, 17, 64, 68, 69, and
140) and Omp. The identification of over-represented categories containing olfactory,
transport, ion channel, and neurosynaptic genes is consistent with the increase in OSN
apoptosis and the resulting decrease in the number of functional OSNs at 48 h following
OBX.
Our next aim was to identify specific statistically significant pairwise effect genes
that are functionally associated with the identified over-represented immune response,
cell cycle and neurogenesis, and growth factor activity EASE categories, in addition to
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apoptosis genes, in order to establish macrophage-mediated neuroprotection and
neurogenesis mechanisms in the OE that result in the induction of OSN survival,
turnover, and maturation following OBX.
Immune Response Genes
Numerous immune response genes (Table 3.5) had significant pairwise effects,
consistent with our previous cellular results that Lip-C sham and OBX mice have 38%
and 35% fewer OE macrophages than Lip-O sham and OBX mice, respectively. As
indicated by the EASE results, nearly all of the main effect immune-associated genes had
mean hybridization signals that were either significantly (p<0.01) or marginally: lower in
the Lip-C mice; up-regulated at 48 h following OBX; or both. These results are
consistent with the decrease in the number of macrophages in the OE of Lip-C mice and
the parallel increase in the number of macrophages in the OE of Lip-O and Lip-C mice at
48 h following OBX.
We identified 3 genes from the scavenger receptor class of genes that had
significant main effects. For example, the expression level of the main effect group and
treatment gene Cd36 (CD36 antigen; Figure 3.2C), a class B scavenger receptor involved
in adhesion and phagocytosis, was 1.2-fold less in Lip-C sham mice compared to Lip-O
sham mice. At 48 h following OBX, the expression of Cd36 was up-regulated 1.7-fold in
Lip-O mice compared to only 1.2-fold in Lip-C mice. The main effect treatment gene
Msr1 (macrophage scavenger receptor 1; Figure 3.2D), a class A scavenger receptor that
mediates the binding of macrophages to apoptotic cells, had a 1.2-fold decrease in the
overall level of expression in Lip-C mice compared to Lip-O mice and a 1.8-fold increase
in expression in OBX mice compared to sham mice. The expression of Msr1 was similar
in the Lip-O and Lip-C sham mice. At 48 h following OBX, Msr1 expression was upregulated 2-fold in Lip-O mice and 1.5-fold in Lip-C mice, resulting in a marginal Lip-C
effect.
We anticipated that genes with significant effects in our model would include
those encoding cytokines, chemokines, and their receptors due to their involvement in
macrophage activation and recruitment, and neuropoietic functions in the OE following
OBX. Accordingly, these genes were well-represented among the significant main effect
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Table 3.5. Selected immune response genes with significant effects: relative group and
treatment fold changes.
Gene
Gene Name
Symbol
Interaction Genes
1418762_at
decay accelerating factor 1
Daf1
1433804_at
Janus kinase 1
Jak1
1451115_at
protein inhibitor of activated STAT3
Pias3
1423349_at
suppressor of cytokine signaling 5
Socs5
Main Effect Group Genes
complement component 9
1422815_at
C9
complement component factor h
1423153_x_at Cfh
colony stimulating factor 1 receptor
1423593_a_at Csf1r
chemokine (C-X-C motif) ligand 7
1418480_at
Cxcl7
chemokine (C-X-C motif) receptor 4
1448710_at
Cxcr4
1418345_at
Tnfsf13 tumor necrosis factor (ligand)
superfamily, member 13
Main Effect Treatment Genes
1434366_x_at C1qb
complement component 1, q
subcomponent, beta polypeptide
complement component 1, q
1449401_at
C1qc
subcomponent, gamma polypeptide
chemokine (C-C motif) ligand 27
1419188_s_at Ccl27
CD8 antigen, beta chain
1448569_at
Cd8b
CD36 antigen
1416050_a_at Cd36
CD68 antigen
1449164_at
Cd68
CD86 antigen
1420404_at
Cd86
CD151 antigen
1424093_x_at Cd151
CD164 antigen
1416440_at
Cd164
interferon regulatory factor 2
1418265_s_at Ifr2
1451775_s_at Il13ra1 interleukin 13 receptor, alpha 1
interleukin 18
1417932_at
Il18
interleukin 10-related T cell-derived
1427624_s_at Iltifb
inducible factor beta
1448668_a_at Irak1
interleukin-1 receptor-associated kinase
1
1420911_a_at Mfge
milk fat globule-EGF factor 8 protein
1438654_x_at Mmd2
monocyte to macrophage
differentiation-associated 2
1448061_at
macrophage scavenger receptor 1
Msr1
1416050_a_at Scarb1
scavenger receptor class B, member 1
1460700_at
signal transducer and activator of
Stat3
transcription 3
1426353_at
signal transducer and activator of
Stat6
transcription 6
Probe set ID
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Lip-C/
Lip-O

OBX/
Sham

1.13
- 1.10
1.15
1.01

- 1.30
-1.24
-1.01
- 1.26

- 3.45
- 1.43
- 1.42
2.62
- 1.37
- 1.63

1.21
1.21
1.28
1.48
1.26
1.28

- 1.12

1.54

- 1.25

2.21

1.11
1.08
- 1.44
- 1.05
- 1.20
- 1.11
- 1.07
- 1.06
- 1.25
1.00
3.72

- 1.32
1.52
1.47
2.54
1.74
1.36
1.23
1.23
1.27
- 1.33
- 5.59

1.11

1.29

- 1.16
- 1.04

1.29
1.30

- 1.17
- 1.44
- 1.04

1.83
1.47
1.42

1.11

1.37

Table 3.5 Continued.
Gene
Lip-C/ OBX/
Gene Name
Symbol
Lip-O Sham
Main Effect Treatment Genes
1418162_at
toll-like receptor 4
- 1.19
Tlr4
1.49
1452440_at
- 1.04
Tnfsf12 tumor necrosis factor (ligand)
1.26
superfamily, member 12
Abbreviations: Lip-C, liposome-encapsulated clodronate; Lip-O, empty liposomes;
Probe set ID

OBX, olfactory bulbectomy. Bold indicates significant effect (p<0.01) as determined by
pairwise comparisons. Negative fold-change indicates down-regulation. Shaded gene
symbols indicate significant main effect group and treatment genes. Significant group
and treatment genes are placed in the category of its lowest p-value.
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Figure 3.2. Microarray expression patterns of four selected immune response genes that
had significant effects. (A) The mean hybridization signal ± standard deviation (SD) of
Daf1 (decay accelerating factor 1) had a significant interaction between group (Lip-C,
Lip-O) and treatment (OBX, sham). (B) The mean hybridization signal of the main effect
group gene C9 (complement component 9) was significantly down-regulated in Lip-C
mice compared to Lip-O mice. (C) The mean hybridization signal of the main effect
group and treatment gene Cd36 (CD36 antigen) was significantly down-regulated in LipC mice compared to Lip-O mice and significantly up-regulated in OBX mice compared
to sham mice. (D) The mean hybridization signal of Msr1 (macrophage scavenger
receptor 1) had significant treatment main effects and marginally significant group main
effects. Abbreviations: Lip-O, empty liposomes (closed circles, dotted lines); Lip-C,
liposome-encapsulated clodronate (open circles, solid lines); OBX, olfactory bulbectomy.
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genes. For example, as noted above, Cxcr4 was identified as a significant group and
treatment effect gene. In addition to the three chemokine-associated main effect genes,
there were four interleukin-associated genes identified as having significant group and/or
treatment main effects, including Il13ra1 (interleukin 13 receptor, alpha 1), a gene that
mediates anti-inflammatory mechisms in macrophages, whose mean hybridization signal
was 1.3-fold significantly lower in Lip-C mice compared to Lip-O mice and 1.3-fold
significantly up-regulated in both groups at 48 h following OBX.
Coinciding with the significant regulation of these extracellular immune signaling
molecules was the significant regulation of members of the intracellular cytokine and
chemokine signaling cascade, including two members of the signal transducer and
activator of transcription family, Stat3 and Stat6, through which neuropoietic cytokines
such as IL-6 and LIF signal. Stat3 and Stat6 were identified as significantly up-regulated
main effect treatment genes. The expression level of Jak1 (Janus kinase 1), the tyrosine
kinase that activates STAT3, had a statistically significant interaction between group and
treatment. Additionally, Socs5 (suppressor of cytokine signaling 5), a cytokine signaling
gene also involved in the regulation of cell growth, was identified as an interaction effect
gene.
There were several complement component-related genes that were distributed
across the interaction and main effect categories. As expected, the mean hybridization
signals for most of these genes were significantly lower in Lip-C mice compared to LipO mice. For example, Daf1 (decay accelerating factor 1; Figure 3.2A), an inhibitor of
phagocytosis of apoptotic cells, was identified as a significant interaction gene.
Additionally, the mean hybridization signal of the main effect group gene C9
(complement component 9; Figure 3.2B) was 3.5-fold significantly lower in Lip-C mice
compared to Lip-O mice, with a 1.2-fold up-regulation in both groups at 48 h following
OBX. Another group of immune response genes that was well-represented among the
significant effect genes were the CD antigen genes, cell-surface molecules that are
expressed by a variety of immune cells and are involved in an array of functions that
include cell adhesion and activation. The six CD antigen genes were identified as
significant main effect treatment genes. The expression levels of all but one of these CD
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antigen genes were lower in Lip-C mice, and all six CD genes were up-regulated at 48 h
following OBX.
The differential regulation of these significant interaction and main effect immune
response genes characterized the decreased innate immune response that was induced by
macrophage depletion in the OE of sham and OBX mice, and identified several genes
involved in this macrophage-mediated immune response.
Growth Factor Genes
Our microarray results identified several novel growth factor genes with
significant effects that may function in the macrophage-mediated neuroprotection of the
OE (Table 3.6). The mean hybridization signals for all of the identified growth factor
genes that had significant interaction effects were lower in Lip-C mice compared to LipO mice, which is consistent with the apparent decrease in neuroprotection observed in
Lip-C mice compared to Lip-O mice at 48 h following OBX. For example, Hdgf (Figure
3.3A) was identified as a gene with a significant interaction that was expressed
significantly lower in Lip-C mice compared to Lip-O mice at 48 h following OBX
(p<0.01; 1.2-fold), as previously discussed. Another growth factor gene with a
significant interaction was Tgfbr1 (transforming growth factor, beta receptor 1; Figure
3.3B), a receptor for TGF-β that promotes the differentiation and maturation of OSN
progenitors. The expression of Tgfbr1 was 1.8-fold greater in the Lip-O sham mice
compared to Lip-C sham mice. At 48 h following OBX, the expression level of Tgfbr1
decreased 1.5-fold in the Lip-O mice and increased 1.2-fold in the Lip-C mice. Pdap1
(PDGFA associated protein 1), a platelet-derived growth factor binding protein, had a
similar graphical pattern of expression as that shown for Tgfbr1.
There were a number of growth factor genes that had significant main effects. All
but two of these genes were up-regulated at 48 h following OBX compared to the sham
mice. The expression level for 11 of the 19 main effect growth factor genes were lower
in the Lip-C mice compared to the Lip-O mice, indicating multiple sources and functions
for these growth factors. There were several members of the Igf (insulin-like growth
factor) family of genes that were overall significantly regulated and had significant main
effects. For example, the expression level of Igfbp3 (IGF binding protein 3; Figure

72

Table 3.6. Selected growth factor genes with significant effects: relative group and
treatment fold changes.
Gene
Symbol
Interaction Genes
1451693_a_at Fgf12
1448571_a_at Gmfb
1415888_at
Hdgf
1434020_at
Pdap1
1420893_a_at Tgfbr1

Probe set ID

Gene Name
fibroblast growth factor 12
glial maturation factor, beta
hepatoma-derived growth factor
PDGFA associated protein 1
transforming growth factor, beta
receptor 1

Lip-C/
Lip-O

OBX/
Sham

- 1.09
- 1.20
- 1.12
- 1.37
- 1.36

- 2.10
- 1.22
1.08
1.07
- 1.19

Main Effect Group Genes
1448326_a_at Crabp1 cellular retinoic acid binding protein 1
1.16
- 1.65
fibroblast growth factor 21
1422916_at
Fgf21
3.70 - 1.04
c-fos induced growth factor
1449528_at
Figf
1.63
1.36
FGF receptor activating protein 1
1424614_at
Frag1
- 1.19
1.13
insulin-like growth factor binding
1.20
1423062_at
Igfbp3
- 1.29
protein 3
insulin-like growth factor binding
1.13
1452114_s_at Igfbp5
1.37
protein 5
Main Effect Treatment Genes
bone morphogenic protein 6
1450759_at
Bmp6
1.31 - 1.87
epidermal growth factor receptor
- 1.14
1424932_at
Egfr
1.23
fibroblast growth factor 9
- 1.04 - 1.87
1438718_at
Fgf9
fibroblast growth factor receptor 1
- 1.02
1424050_s_at Fgfr1
1.37
fibroblast growth factor receptor 2
- 1.10
1420847_a_at Fgfr2
1.22
fibroblast growth factor receptor-like 1
- 1.04
1447878_s_at Fgfrl1
1.34
growth factor receptor bound protein 21.06
1417693_a_at Gab1
1.37
associated protein 1
growth factor receptor bound protein 14 - 1.14
1417673_at
Grb14
1.32
heparin-binding EGF-like growth factor
1418350_at
Hbdgf
1.35
1.41
insulin-like growth factor 1
- 1.05
1419519_at
Igf1
2.04
insulin-like growth factor 2 receptor
1424111_at
Igf2r
1.23
1.24
insulin-like growth factor binding
1.05
1417933_at
Igfbp6
1.33
protein 6
neurotrophic tyrosine kinase, receptor,
1420838_at
Ntrk2
1.23
1.24
type 2
platelet-derived growth factor, C
- 1.09
1419123_a_at Pdgfc
1.22
polypeptide
retinoic acid receptor, beta
- 1.14
1454906_at
Rarb
1.25
transforming growth factor, beta
- 1.04
1426397_at
Tgfbr2
1.29
receptor 2
Table 3.6 Abbreviations: Lip-C, liposome-encapsulated clodronate; Lip-O, empty
liposomes; OBX, olfactory bulbectomy. Bold indicates significant effect (p<0.01) as
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determined by pairwise comparisons. Negative fold-change indicates down-regulation.
Shaded gene symbols indicate significant main effect group and treatment genes.
Significant group and treatment genes are placed in the category of its lowest p-value.
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Figure 3.3. Microarray expression patterns of four selected growth factor genes that had
significant effects. (A, B) The mean hybridization signals ± standard deviation (SD) of
Hdgf (hepatoma-derived growth factor) and Tgfbr1 (transforming growth factor, beta
receptor 1) had significant interactions between group (Lip-C, Lip-O) and treatment
(OBX, sham). (C) The mean hybridization signal of the main effect group gene Igfbp3
(insulin-like growth factor binding protein 3) was significantly down-regulated in Lip-C
mice compared to Lip-O mice and marginally significantly up-regulated at 48 h following
OBX. Igfbp3 also had a marginally significant interaction effect. (D) The mean
hybridization signal of Rarb (retinoic acid receptor, beta) had significant treatment main
effects due to the significant up-regulation at 48 h following OBX in both groups and was
marginally significantly down-regulated in Lip-C mice compared to Lip-O mice.
Abbreviations: Lip-O, empty liposomes (closed circles, dotted lines); Lip-C, liposomeencapsulated clodronate (open circles, solid lines); OBX, olfactory bulbectomy.
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3.3C), was 1.1-fold lower in Lip-C sham mice compared to Lip-O sham mice. At 48 h
following OBX, the expression of Igfbp3 increased 1.4-fold in the Lip-O mice but stayed
relatively constant in the Lip-C mice. However, Igfbp3 was statistically identified as a
main effect group gene with a marginally significant interaction effect. Igf1 was
identified as a 2-fold up-regulated main effect treatment gene that was expressed at a
marginally lower level (1.1-fold) in Lip-C mice compared to Lip-O mice.
Our microarray analysis identified seven Fgf (fibroblast growth factor) genes that
had significant pairwise effects. The FGF receptor genes Fgfr1 (1.4-fold), Fgfr2 (1.2fold), and Fgfrl1 (1.3-fold) were identified as significantly up-regulated main effect
treatment genes that were marginally down-regulated in Lip-C mice compared to Lip-O
mice. Additionally, the mean hybridization signals of Fgf9 (treatment, 1.9-fold downregulated) and Fgf21 (group, 3.7-fold up-regulated) had significant main effects while
Fgf12 had a significant interaction effect. The receptor for EGF (epidermal growth
factor), Egfr, was identified as a 1.2-fold significantly up-regulated main effect treatment
gene, with marginal interaction and group (1.1-fold down-regulated) effects. There were
two retinoic acid (RA)-associated genes that had significant main effects, Crabp1
(cellular retinoic acid binding protein 1) and Rarb (retinoic acid receptor, beta; Figure
3.3D).
Taken together, the identification of these growth factor genes with significant
interaction and main effects that were down-regulated in Lip-C mice compared to Lip-O
mice characterizes one or more mechanisms by which macrophages mediate OSN
survival following OBX.
Cell Cycle and Neurogenesis Genes
Our EASE analysis identified several cell cycle gene categories that were overrepresented, consistent with the decrease in basal cell proliferation in the OE of Lip-C
sham and OBX mice compared to Lip-O mice. Among the cell cycle and neurogenesis
genes that had significant pairwise effects (Table 3.7) were several transcription factors.
The mean hybridization signals of these transcription factor genes were typically lower in
the Lip-C mice compared to Lip-O mice and up-regulated at 48 h following OBX. Most
notably, the expression level of the main effect group and treatment gene Ngn1
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Table 3.7. Selected cell cycle and neurogenesis genes with significant effects: relative
group and treatment fold changes.
Gene
Symbol
Interaction Genes
1430127_a_at Ccnd2
1418585_at
Ccnh
1428092_at
Cdc5l
1437070_at
Cdc14b
Probe set ID

Lip-C/
Lip-O

Gene Name
cyclin D2
cyclin H
cell division cycle 5-like
CDC14 cell division cycle 14
homolog B (S. cerevisiae)
cyclin-dependent kinase 9
cyclin-dependent kinase-like 2
cyclin-dependent kinase inhibit 1B
neurogenic differentiation 1

- 1.11
1.06
- 1.07
- 1.15

OBX/
Sham
1.40
- 1.18
- 1.12
1.18

1417269_at
1.04
Cdk9
- 1.14
1457625_s_at Cdkl2
- 1.15
- 1.76
1419497_at
- 1.45
Cdkn1b
- 1.16
1426412_at
Neurod1
- 3.62
1.27
Main Effect Group Genes
1418271_at
basic helix-loop-helix domain
1.31
Bhlhb5
- 1.35
containing, class B5
1448205_at
cyclin B1
1.53
Ccnb1
- 1.58
1415907_at
cyclin D3
1.15
Ccnd3
1.22
1460389_at
cyclin-depended kinase 8
- 1.11
Cdk8
1.17
1436050_x_at Hes6
hairy and enhancer of split 6
- 1.69
1.26
(Drosophila)
1438551_at
neurogenin 1
Ngn1
- 2.91
1.44
1416967_at
SRY-box containing gene 2
1.16
Sox2
- 1.28
Main Effect Treatment Genes
cyclin-dependent kinase 4
1422439_a_at Cdk4
- 1.16
1.21
Abbreviations: Lip-C, liposome-encapsulated clodronate; Lip-O, empty liposomes;
OBX, olfactory bulbectomy. Bold indicates significant effect (p<0.01) as determined by
pairwise comparisons. Negative fold-change indicates down-regulation. Shaded gene
symbols indicate significant main effect group and treatment genes. Significant group
and treatment genes are placed in the category of its lowest p-value.
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(neurogenin 1; Figure 3.4C), a bHLH (basic helix-loop-helix) transcription factor that is
expressed by proliferating basal cells, was 2.8-fold lower in the Lip-C sham mice
compared to Lip-O sham mice. At 48 h following OBX, the expression of Ngn1 was 1.5fold and 1.4-fold up-regulated in Lip-O and Lip-C mice, respectively. The transcription
factors Sox2, a down-regulated main effect gene as noted above, and Hes6, a gene
expressed by OSN progenitors that promotes neuronal differentiation, displayed similar
graphical patterns of expression as Ngn1. Another bHLH transcription factor, Neurod1, a
gene expressed in proliferating and differentiating OSN progenitors, had a mean
hybridization signal that was 3.6-fold significantly lower in Lip-C sham mice compared
to Lip-O sham mice. At 48 h following OBX, the expression of Neurod1 increased 1.4fold in the Lip-O mice but stayed relatively constant in the Lip-C mice, qualifying it as an
interaction gene.
Additional cell cycle regulatory genes that had significant pairwise effects
included several cyclin-associated genes. For example, the promoters of cell
proliferation Cdc5l (cell division cycle 5-like; Figure 3.4A), Cdkl2 (cyclin-dependent
kinase-like 2; Figure 3.4B), and Ccnd2 (cyclin D2) were identified as significant
interaction genes. Cdc51 and Cdkl2 were expressed 1.3-fold and 1.4-fold less in Lip-C
sham mice compared to Lip-O sham mice, respectively. At 48 h following OBX, the
expression level of Cdc5l decreased in the Lip-O mice and increased in the Lip-C mice,
resulting in intersecting patterns of expression. The expression of Cdkl2 decreased 2.4fold in the Lip-O mice compared to 1.3-fold in the Lip-C mice at 48 h following OBX,
also resulting in intersecting patterns of expression. The mean hybridization signal of
Cdk4 (cyclin-dependent kinase 4; Figure 3.4D), a catalytic partner of the G1/S-phase
specific D-type cyclins, was 1.2-fold significantly lower in Lip-C mice compared to LipO mice and 1.2-fold significantly up-regulated in each group at 48 h following OBX,
resulting in significant group and treatment main effects.
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Figure 3.4. Microarray expression patterns of four selected cell cycle/neurogenesis
genes that had significant effects. (A, B) The mean hybridization signals ± standard
deviation (SD) of the two cyclin genes Cdc5l (cell division cycle 5-like) and Cdkl2
(cyclin-dependent kinase-like 2) had significant interactions between group (Lip-C, LipO) and treatment (OBX, sham). (C, D) The mean hybridization signals of the main effect
group and treatment genes Ngn1 (neurogenin 1) and Cdk4 (cyclin-dependent kinase 4)
were significantly down-regulated in Lip-C mice compared to Lip-O mice and
significantly up-regulated at 48 h following OBX. Abbreviations: Lip-O, empty
liposomes (closed circles, dotted lines); Lip-C, liposome-encapsulated clodronate (open
circles, solid lines); OBX, olfactory bulbectomy.
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Apoptosis Genes
Our microarray analysis identified pro- and anti-apoptosis genes that had
significant interaction and main effects with a variety of expression patterns (Table 3.8).
These genes consisted of extrinsic and intrinsic apoptosis signaling pathway genes.
There were three Tnfr- (tumor necrosis factor receptor)-associated genes (Tnfrsf21, Traf3,
Traf3ip1) and two Fas-associated genes (Faim, Faim2), members of the extrinsic
pathway death receptor family of genes, that had higher mean hybridizations signals in
the Lip-C mice compared to the Lip-O mice and were down-regulated at 48 h following
OBX.
There were several members of the pro-apoptosis Bcl family of mitochondrial
signaling apoptosis genes that were overall significantly regulated with a variety of
significant pairwise effects. For example, the expression level of the interaction gene
Bnip2 (BCL2/adenovirus E1B 19kDa-interacting protein 1, NIP2; Figure 3.5A), an
activator of apoptosis, was 1.1-fold greater in Lip-O sham mice compared to Lip-C sham
mice. At 48 h following OBX, the expression of Bnip2 was 1.5-fold down-regulated in
the Lip-O mice and 1.1-fold up-regulated in the Lip-C mice, resulting in intersecting
graphical patterns of expression. The pro-apoptosis antagonist of Bcl2, Bak1 (BCL2antagonist/killer 1; Figure 3.5B), was identified as a 1.3-fold significantly up-regulated
main effect group gene that was up-regulated (1.1-fold; p=0.08) at 48 h following OBX.
In addition to the pro-apoptosis Bcl family members, a number of cysteine
proteases had significant effects, namely the effector caspases Casp3 (group, 1.4-fold
down-regulated; treatment, 1.3-fold up-regulated), Casp6 (treatment, 1.2-fold downregulated), and Casp7 (treatment, 1.3-fold up-regulated), in addition to Casp12
(treatment, 1.7-fold up-regulated). The expression level for the activator of the effector
caspases, Casp8, was 1.5-fold significantly up-regulated in OBX mice with no significant
Lip-C effect. Another significant main effect group and treatment gene, Apaf1 (apoptosis
protease activating factor 1; Figure 3.5C), that, with cytochrome c, activates caspase-9 in
the intrinsic apoptosis signaling cascade, had a 1.5-fold significantly down-regulated
level of expression at 48 h following OBX compared to sham mice and a 1.3-fold
significantly greater level of expression in the Lip-C mice compared to the Lip-O mice.
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Table 3.8. Selected pro- and anti-apoptosis genes with significant effects: relative group
and treatment fold changes.
Gene
Symbol
PRO-APOPTOSIS
Interaction Genes
1422491_a_at Bnip2*
Probe set ID

1417040_a_at

Bok*

1422483_a_at Cycs*
1451453_at
Dapk2
Main Effect Group Genes
1418991_at
Bak1*
1426165_a_at Casp3

Gene Name

BCL2/adenovirus E1B 19kDainteracting protein 1, NIP2
Bcl-2-related ovarian killer
protein
cytochrome c, somatic
death-associated kinase 2

BCL2-antagonist/killer 1
caspase-3, apoptosis-related
cysteine protease
growth arrest and DNA-damage1453851_a_at Gadd45g
inducible 45 gamma
Main Effect Treatment Genes
apoptosis-associated tyrosine
1416936_at
Aatk
kinase
apoptosis protease activating
Apaf1*
1452870_at
factor 1
BCL2-like 2
Bcl2l2*
1423572_at
BCL2-like 11
1456005_a_at Bcl2l11*
BCL2-like 14
Bcl2l14*
1429347_at
caspase-6
1415995_at
Casp6
caspase-7
1448659_at
Casp7
caspase-8
Casp8**
1424552_at
caspase-12
1449297_at
Casp12
programmed cell death protein 6
1415937_s_at Pdcd6ip
interacting protein
programmed cell death protein 11
1420056_s_at Pdcd11
phosphatidylserine receptor
1428688_at
Ptdsr
tumor necrosis factor receptor
1422740_at
Tnfrsf21**
superfamily, member 21
Tnf receptor-associated factor 3
1418587_at
Traf3**
Traf3ip1**
Tnf receptor-associated factor 3
1452887_at
interacting protein 1
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Lip-C/
Lip-O

OBX/
Sham

- 1.09

- 1.07

- 1.01

- 1.26

- 1.01
- 1.22

- 1.09
1.06

1.29
- 1.42

1.09
1.25

- 1.55

1.33

1.52

- 1.82

1.25

- 1.54

1.10
- 1.20
- 1.04
1.06
- 1.12
- 1.01
- 1.07
1.11

- 1.22
1.46
1.52
- 1.17
1.30
1.46
1.69
1.22

1.07
1.15
1.10

1.08
- 1.41
- 1.36

1.12
1.26

- 1.30
- 1.41

Table 3.8 Continued.
Gene
Symbol
ANTI-APOPTOSIS
Interaction Genes
1443837_x_at Bcl2*
1450231_a_at Birc4*
Probe set ID

1450036_at

Sgk3

Gene Name

B-cell leukemia/lymphoma 2
baculoviral IAP repeat-containing
4
serum/glucocorticoid regulated
kinase 3

Lip-C/
Lip-O

OBX/
Sham

1.34
- 1.21

- 1.07

1.08

- 1.19
1.01

Main Effect Group Genes
apoptosis inhibitor 5
1439214_a_at Api5
- 1.21 - 1.21
Main Effect Treatment Genes
1418029_at
Faim**
Fas apoptotic inhibitory molecule
1.15
- 1.74
1429518_at
Faim2** Fas apoptotic inhibitory molecule 2
1.05
- 2.07
Abbreviations: Lip-C, liposome-encapsulated clodronate; Lip-O, empty liposomes;
OBX, olfactory bulbectomy; *, intrinsic apoptosis pathway; **, extrinsic apoptosis
pathway. Bold indicates significant effect (p<0.01) as determined by pairwise
comparisons. Negative fold-change indicates down-regulation. Shaded gene symbols
indicate significant main effect group and treatment genes. Significant group and
treatment genes are placed in the category of its lowest p-value.
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Figure 3.5. Microarray expression patterns of six selected apoptosis genes that had
significant effects. (A-C) Three pro-apoptosis genes. (A) The mean hybridization signal
± standard deviation (SD) of the pro-apoptosis gene Bnip2 (BCL2/adenovirus E1B
19kDa-interacting protein 1, NIP2) had a significant interaction between group (Lip-C,
Lip-O) and treatment (OBX, sham). (B) The mean hybridization signal of the proapoptosis main effect group gene Bak1 (BCL2-antagonist/killer 1) was significantly upregulated in Lip-C mice compared to Lip-O mice. (C) The mean hybridization signal of
the pro-apoptosis gene Apaf1 (apoptosis protease activating factor 1) had significant
group and treatment main effects due to the significant up-regulation in Lip-C mice
compared to Lip-O mice and significant down-regulation at 48 h following OBX in both
groups. (D-F) Three anti-apoptosis genes. (D) The mean hybridization signal of the anti85

apoptosis gene Bcl2 (B-cell leukemia/lymphoma 2) had a significant interaction between
group and treatment. (E) The mean hybridization signal of the anti-apoptosis main effect
group and treatment gene Api5 (apoptosis inhibitory 5) was significantly down-regulated
in Lip-C mice compared to Lip-O mice and at 48 h following OBX in both groups. (F)
The mean hybridization signal of the anti-apoptosis gene Faim2 (Fas apoptotic inhibitory
molecule 2) had a significant treatment main effect due to the significant down-regulation
in both groups at 48 h following OBX. Abbreviations: Lip-O, empty liposomes (closed
circles, dotted lines); Lip-C, liposome-encapsulated clodronate (open circles, solid lines);
OBX, olfactory bulbectomy.
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In contrast to the large number of pro-apoptosis genes identified with significant
pairwise effects, there were only six anti-apoptosis genes that had significant effects.
Most notably, Bcl2 (B-cell leukemia/lymphoma 2; Figure 3.5D) was identified as a
significant interaction gene. The expression level of the main effect group and treatment
gene Api5 (apoptosis inhibitor 5; Figure 3.5E) was 1.2-fold significantly lower in Lip-C
and OBX mice. Faim2 (Fas apoptotic inhibitory molecule 2; Figure 3.5F) was identified
as a main effect treatment gene due to the significant 2-fold down-regulation in the level
of expression in both Lip-O and Lip-C OBX mice compared to sham mice.
The identification of these pro- and anti-apoptosis genes with significant effects
suggests several mechanisms that underlie the increase in apoptosis in the OE of Lip-C
mice compared to the Lip-O mice at 48 h following OBX.
Molecular Validation Using qPCR
In order to validate the data from the microarray experiment, qPCR was
performed on seven genes carefully selected based on our hypothesis that macrophages
promote OSN survival and replacement in the OE (Table 3.2). The microarray
hybridization patterns of the interaction genes Ccnd2, Socs5, Pdap1, and Neurod1
(Figure 3.6); and of the main effect genes Omp (treatment), Cxcr4 (group/treatment), and
Crabp1 (group; Figure 3.7) were validated by qPCR mean quantity patterns. For each
gene, the graphical patterns of the qPCR mean quantities (Figures 3.6 and 3.7, left
column) were similar to that of the microarray hybridization signals (Figures 3.6 and 3.7,
right column). The qPCR graphical pattern for the main effect gene Crabp1 (Figure
3.7E) was slightly different than that of the microarray hybridization pattern (Figure
3.7F). However, the group (Lip-C/Lip-O) and treatment (OBX/sham) fold changes of the
mean quantities for Crabp1 from the qPCR were comparable to those from the
microarray analysis, as were the fold changes for the other six genes (Table 3.9).
The relative abundance of each gene was estimated from the relative CT values
that were generated from 3-4 serial dilutions for each gene (Figure 3.8A). Each standard
CT curve was well fitted (R2 ≥ 0.97), and the qPCR products were of the expected size as
identified by a 2% agarose gel (Figure 3.8B) and had the appropriate melting temperature
(Table 3.2).
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Figure 3.6. Validation of the microarray expression patterns of the four selected genes
with a significant interaction using real-time RT-PCR (qPCR). The patterns of the mean
quantities (ng) ± standard deviation (SD) determined by qPCR (left column) of Ccnd2
(A), Socs5 (C), Pdap1 (E), and Neurod1 (G) showed positive validation of the microarray
results, as shown by the patterns of the mean hybridization signals ± SD for each gene (B,
D, F, H, respectively). Solid circles/dotted lines, empty liposome-treated (Lip-O) mice;
open circles/solid lines, liposome-encapsulated clodronate-treated (Lip-C) mice. Ccnd2,
cyclin D2; Socs5, suppressor of cytokine signaling 5; Pdap1, PDGFA associated protein
1; Neurod1, neurogenic differentiation 1.
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Figure 3.7. Validation of the microarray expression patterns of the three selected genes
with significant main effects using real-time RT-PCR (qPCR). The patterns of the mean
quantities (ng) ± standard deviation (SD) determined by qPCR (left column) of Omp (A)
and Cxcr4 (C) showed positive validation of the microarray results, as shown by the
patterns of the mean hybridization signals ± SD for each gene (B and D, respectively).
The qPCR pattern of the mean quantity for Crabp1 (E) was slightly different than the
pattern of the mean hybridization signals (F) where, following OBX, the mean quantity
decreased in the empty liposome-treated (Lip-O) mice as opposed to increasing as in the
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microarray analysis. Solid circles/dotted lines, empty liposome-treated (Lip-O) mice;
open circles/solid lines, liposome-encapsulated clodronate-treated (Lip-C) mice. Omp,
olfactory marker protein; Cxcr4, chemokine (C-X-C motif) receptor 4; Crabp1, cellular
retinoic acid binding protein 1.
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Table 3.9. Fold changes of genes from qPCR and microarray experiments.
Gene
Symbol

Lip-C/Lip-O

qPCR
Interaction Genes
1.03
Ccnd2
1.15
Socs5
- 1.11
Pdap1
Neurod1
- 2.99

OBX/Sham

Microarray

qPCR

Microarray

- 1.11
1.01
- 1.37
- 3.62

1.64
- 1.22
1.05
1.36

1.40
- 1.27
- 1.08
1.27

Main Effect Genes
- 1.05
1.09
Omp
- 2.91
- 1.89
1.11
1.16
Crabp1
- 1.68
- 1.64
1.31
Cxcr4
- 1.56
- 1.37
1.26
Abbreviations: Lip-C, liposome-encapsulated clodronate; Lip-O, empty liposomes;
OBX, olfactory bulbectomy. Negative fold-change indicates down-regulation. Shading
indicates positive statistical validation of microarray fold changes by qPCR. Bold
indicates significant effect (p<0.01) as determined by pairwise comparisons.
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Figure 3.8. Standard curves and 2% agarose gel of real-time RT-PCR (qPCR) aplicons.
(A) Relative abundance of the seven selected genes with significant interaction and main
effects. The comparative threshold (CT) values of the linear regression standard curves
were used to calculate the relative abundance for the selected genes. Each standard curve
was well fitted (R2 ≥ 0.97). (B) Verification of a single real-time RT-PCR product and its
expected size by a 2% agarose gel. Each amplicon was of the expected size, given in
Table 2, and contained a single band. Omp showed slight primer-dimer formation (~45
bp) that was present in the no-template control and accounted for when calculating
quantities. Neurod1, neurogenic differentiation 1 (R2 = 0.98); Cxcr4, chemokine (C-X-C
motif) receptor 4 (R2 = 0.98); Ccnd2, cyclin D2 (R2 = 0.97); Socs5, suppressor of
cytokine signaling 5 (R2 = 0.99); Pdap1, PDGFA associated protein 1 (R2 = 0.99);
Crabp1, cellular retinoic acid binding protein 1 (R2 = 0.99); Omp, olfactory marker
protein (R2 = 0.97).
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Immunohistochemistry
Cxcr4, identified as a significant main effect group and treatment gene that was
expressed at a lower level in the Lip-C mice compared to the Lip-O mice and upregulated following OBX, has been reported to be involved in axon guidance, leukocyte
trafficking, and cell migration, all important processes that occur within the OE following
OBX-induced apoptosis of OSNs. Since macrophages are known to express and secrete
SDF-1, the ligand for CXCR4, we localized SDF-1 on sections adjacent to sections
stained with the macrophage-specific marker CD68 (Figure 3.9). Based on the
distribution and localization of SDF-1 and CD68 immunoreactivity on adjacent sections
within the same regions of the OE, it appeared that SDF-1 was expressed by a
subpopulation of CD68+ macrophages (Figure 3.9B, D, F, and H). The amount of SDF-1
immunoreactivity was similar between Lip-O and Lip-C sham mice (Figure 3.9A and E).
At 48 h following OBX, immunoreactivity for SDF-1 increased in both Lip-O and Lip-C
mice (Figure 3.9C and G). This data was consistent with the microarray expression
pattern of Sdf1, which increased in both groups at 48 h following OBX (p≥0.01).
The microarray expression pattern of the significant interaction gene Hdgf was
validated on the protein level using immunohistochemistry (Figure 3.10). Comparable to
the microarray expression pattern (Figure 3.3A), the amount of HDGF immunoreactivity
was similar in the OE of Lip-O and Lip-C sham mice (Figure 3.10A and C). At 48 h
following OBX, HDGF immunoreactivity was greatly increased in the OE of Lip-O mice
and marginally increased in the OE of Lip-C mice (Figure 3.10B and D). HDGF
immunoreactivity was localized in the basal cell layer of Lip-O and Lip-C sham mice. At
48 h following OBX, HDGF immunoreactivity was localized in the OSN and basal cell
layers.
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Figure 3.9. Immunohistochemical comparison of SDF-1 and CD68 expression on
adjacent sections of olfactory epithelium (OE). (A and E) Expression of SDF-1 (stromal
cell-derived factor 1; arrows) was comparable between Lip-O and Lip-C sham mice. (C
and G) At 48 h following OBX, SDF-1 expression increased in both Lip-O and Lip-C
mice, but to a greater extent in Lip-O mice. (B, D, F, and H) SDF-1 immunoreactivity
appeared to be localized to a subpopulation of CD68+ macrophages (arrows) in Lip-O
and Lip-C sham and OBX mice. Images are from the same region of OE on adjacent
sections. OE delimited by arrowheads. Scale bar = 50 μm.
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Figure 3.10. Immunohistochemical validation of the microarray expression pattern of
the interaction gene Hdgf in the olfactory epithelium (OE). (A and C) Comparable to the
microarray expression pattern, HDGF (hepatoma-derived growth factor; arrows) was
expressed at similar levels in the OE of Lip-O and Lip-C sham mice. HDGF
immunoreactivity appeared to be localized to basal cells. (B and D) At 48 h following
OBX, HDGF expression increased significantly in the OE of Lip-O mice but not in the
OE of Lip-C mice, comparable to the microarray expression pattern of Hdgf, and
appeared to be localized to basal cells and olfactory sensory neurons. OE delimited by
arrowheads. Scale bar = 50 μm.
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Discussion
The results of this study demonstrate that: 1) clodronate-induced macrophage
depletion in the OE results in significantly altered expression levels of a large number of
genes with complex patterns of regulation between group (Lip-O, Lip-C) and treatment
(sham, OBX); 2) immune response, growth factor activity, nucleotide activity, cell cycle,
and cytoskeleton were among the GO functional categories of genes that were
significantly over-represented within the genes that had significant pairwise effects; and
3) cellular localization of SDF-1 and HDGF characterized novel macrophage-mediated
molecular mechanisms regulating neuroprotection and neurogenesis in the OE. These
results identified a number of molecular pathways by which macrophage depletion in the
OE may lead to decreased OSN maturation, survival, and turnover through the regulation
of gene expression.
Graphical and Statistical Pattern Analysis
We recently introduced the use of liposome-encapsulated clodronate to
significantly reduce the number of macrophages in the unperturbed OE and in the OE
following OBX (Borders et al., 2006). In this study we used a microarray expression
pattern analysis to identify genes that were differentially expressed in our model of
decreased neurogenesis and neuroprotection in macrophage-depleted sham and OBX
mice. Pairwise comparisons identified genes whose response to OBX was either
significantly or not significantly different between the Lip-O and Lip-C mice (interaction
and main effect, respectively).
The 980 interaction genes represent those genes whose expression patterns were
significantly modulated by Lip-C treatment, and thus macrophage depletion, at 48 h
following OBX. The interaction effect is most likely due to fewer macrophages available
to respond (by phagocytosis of apoptotic cells and the secretion of bioactive molecules
that include cytokines, chemokines, and growth factors) to OBX-induced OSN apoptosis
in Lip-C mice. The 3,044 genes with a significant main effect are those whose
expression pattern was not significantly modulated by the macrophage response to OBXinduced OSN apoptosis, but those whose expression levels were significantly different as
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a result of either macrophage depletion (n=364), OBX (n=2,266), or both (n=414). The
microarray expression patterns of four significant interaction genes (Ccnd2, Socs5,
Pdap1, and Neurod1) and three main effect genes (Omp, treatment; Cxcr4 and Crabp1,
group) were validated by qPCR while the group (Lip-C/Lip-O) and treatment
(OBX/sham) fold changes were comparable between the microarray and qPCR data for
these genes.
OBX induces apoptosis in OSNs via the caspase pathway (Carson et al., 2005;
Cowan et al., 2001). We identified a number of pro- and anti-apoptosis genes that had
significant pairwise effects in our model. However, since most genes have multiple
functions and we induced apoptosis in two cell types in the OE, OSNs and macrophages,
it is difficult to entirely distinguish between pro- and anti-apoptosis gene functions in our
model.
OBX-Induced Macrophage Activation
OBX-induced apoptosis of OSNs results in activation of resident OE
macrophages. Macrophage activation in the OE is regulated in part through the binding
of exposed ligands, including phosphatidylserine, on the apoptotic OSNs to scavenger
receptors (SRs) on the macrophage plasma membrane (Getchell et al., 2006), most
notably MSR-1, CD36, and SCARB-1 as indicated in our proposed model (Figure 3.11).
These three SR genes were identified as significant group and/or treatment main effect
genes that were expressed at lower levels in the Lip-C mice compared to the Lip-O mice
and significantly up-regulated at 48 h following OBX. The previous study from our
laboratory using a transgenic mouse model in which the Msr1 gene was disrupted
demonstrated decreased macrophage infiltration into the OE at multiple time points
following OBX (Getchell et al., 2006). Additionally, immune response genes, including
other phagocytosis-related genes, were expressed at primarily lower levels in the
transgenic model compared to wild-type mice and were up-regulated at multiple time
points following OBX, which was confirmed and extended in this study as indicated by
the EASE results. Interestingly, binding of apoptotic cells to scavenger receptors has
been reported to result in the alternative activation of macrophages (Duffield 2003). As a
result, two markers of alternative activation were identified as significantly regulated:
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Figure 3.11. Proposed model of macrophage-mediated molecular mechanisms of
olfactory sensory neuron (OSN) survival and regeneration. At 48 h following OBX,
apoptotic OSNs activate resident macrophages (red) via scavenger receptors (SR; for
example MSR-1, CD36, SCARB-1). Binding of apoptotic OSNs to scavenger receptors
on the macrophages up-regulates the expression of Il13ra1 and Mrc1 (MR). The
activated macrophages then secrete a number of potential growth and survival factors that
may include IGF-1, RA, and HDGF, which act upon OSNs in order to delay/prevent
apoptosis. Additionally, macrophages that are recruited into the OE by MIP-1α and
MCP-1 induce globose basal cell proliferation through LIF binding to its receptor, LIFR,
resulting in the up-regulation of cyclin-related genes and the neurogenesis bHLH TFs
Hes6, Ngn1, and Neurod1. The daughter cells of globose basal cell division that are
committed to the OSN lineage express HDGF as a survival or proliferative factor.
Macrophages also likely secrete a number of molecules, including SDF-1, TGF-β, and
RA to promote the survival, differentiation, and maturation of OSN progenitor cells.
Abbreviations: mOSN, mature olfactory sensory neuron; GBC, globose basal cell; OB,
olfactory bulb; OBX, olfactory bulbectomy; OE, olfactory epithelium; SR, scavenger
receptor; MSR-1, macrophage scavenger receptor-1; SCARB-1, scavenger receptor class
B-1; I13ra1, interleukin 13 receptor, alpha 1; Mrc1, mannose receptor, C type 1; IL13R,
interleukin 13 receptor; MR, mannose receptor, C type 1; IGF-1, insulin-like growth
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factor-1; RA, retinoic acid; HDGF, hepatoma-derived growth factor; CRABP1, cellular
retinoic acid binding protein 1; IGFBP, insulin-like growth factor binding protein; MIP1α, macrophage inflammatory protein-1α; MCP-1, monocyte chemoattractant protein-1;
LIF, leukemia inhibitory factor; LIFR, LIF receptor; SDF-1, stromal cell-derived factor1; TGF-β, transforming growth factor beta; TGFβR, transforming growth factor beta
receptor; TF, transcription factors; CXCR4, chemokine (C-X-C motif) receptor 4;.
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Il13ra1 (interleukin 13 receptor, alpha 1), which mediates anti-inflammatory mechanisms
in macrophages and up-regulates the expression of the mannose receptor; and Mrc1
(mannose receptor, C type 1), which is involved in cell adhesion and up-regulates the
expression of arginase, leading to the production of anti-inflammatory mediators (Gordon
2002).
Macrophage-Mediated OSN Survival
Since we previously reported that partial macrophage depletion (38% and 35% in
sham and 48 h OBX mice, respectively) in the OE resulted in increased OSN apoptosis at
48 h following OBX and decreased numbers of mOSNs in sham and OBX mice (Borders
et al., 2006), we hypothesized that macrophages secrete growth and survival factors to
delay or prevent apoptosis in OSNs. Based on our microarray analysis, these factors may
include IGF-1 and/or RA, both of which have been reported to promote the survival of
OSNs in vivo and in vitro (Hagglund et al., 2006; Pixley et al., 1998; Rawson et al., 1996;
Schwob, 2002), while IGF-1R (IGF-1 receptor) has been localized to OSNs and basal
cells (McCurdy et al., 2005; Pixley et al., 1998; Suzuki and Takeda, 2002; Whitesides et
al., 1998). Igf1 was a significantly up-regulated main effect treatment gene that was
marginally down-regulated in Lip-C mice compared to Lip-O mice. Additionally, IGF
signaling proteins, including Igf2r, Igfbp3, Igfbp5, and Igfbp6 were up-regulated at 48 h
following OBX. Igf2r, Igfbp5, and Igfbp6 were up-regulated while Igfbp3 was downregulated in Lip-C mice compared to Lip-O mice. The main effect group gene Crabp1, a
signaling molecule for RA that has been localized to the OSN and basal cell layers of the
OE (Asson-Batres et al., 2003; Asson-Batres and Smith, 2006), was expressed at a
significantly lower level in the Lip-C mice compared to Lip-O mice and was marginally
significantly up-regulated at 48 h following OBX, while Rarb (retinoic acid receptor,
beta) was identified as a significantly up-regulated main effect treatment gene that was
marginally down-regulated in Lip-C mice. Hdgf, which has been reported to promote
neuronal survival (Marubuchi et al., 2006; Zhou et al., 2004), may also be a macrophagemediator of OSN survival following OBX. However, the extracellular function of HDGF
is not well-characterized.
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Chemoattraction and Maintenance of Structure
It was previously reported that macrophage activation in the OE following OBX
subsequently results in the secretion of chemoattractants, including MIP-1α and MCP-1,
to recruit additional macrophages into the OE (Getchell et al., 2006; Getchell et al.,
2002c; Kwong et al., 2004). Based on the decrease in OE thickness in the Lip-C sham
and OBX mice compared to the Lip-O mice, it is also possible that the activated
macrophages secrete molecules or enzymes that regulate the expression of cytoskeletal
and extracellular matrix components to promote the trafficking of leukocytes, axon
guidance, and/or migration of leukocytes and newly generated OSNs and their
progenitors. Consistent with this hypothesis was the over-representation of cytoskeletonrelated genes, including genes that encode actins and microtubule-associated proteins,
among the significant interaction genes and of structure-associated genes, including
genes that encode actins, tubulins, and laminins, among the significantly up-regulated
main effect treatment genes identified by the EASE analysis, which is consistent with
previous findings that demonstrated that contact signaling genes, e.g., integrins and
cadherins, were differentially regulated at multiple time points following OBX (Getchell
et al., 2005). A majority of these cytoskeleton and extracellular matrix genes were
expressed at a lower level in the Lip-C mice compared to Lip-O mice. These results
indicate that macrophages regulate the degeneration of mOSNs and the remodeling of the
OE at 48 h following OBX through the expression of structural constituents and/or
enzymes that regulate them.
Induction of Basal Cell Proliferation, Differentiation, and Maturation
The temporal recruitment and infiltration of macrophages into the OE following
OBX coincides with the increase in basal cell proliferation as determined by BrdU
labeling, and with the up-regulation of LIFR, the receptor for the neuropoietic cytokine
LIF, on basal cells (Nan et al., 2001). LIF mRNA was detected in macrophages and
OSNs following OBX (Getchell et al., 2002b), indicating that macrophages are not the
only regulators of basal cell proliferation. There is additional evidence that OSNs
themselves and other cells regulate the proliferation and differentiation of their
progenitors through the expression of bone morphogenic proteins (BMPs) 2, 4, 7, and 12,
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and FGFs 2 and 8 (Calof et al., 2002; Calof et al., 1991; Mahanthappa and Schwarting,
1993; Newman et al., 2000; Schwob, 2002; Shou et al., 2000). While these molecules
were not differentially expressed in our model, Bmp6, which is expressed by OSNs
(Peretto et al., 2002), was identified as a significantly up-regulated main effect group
gene and a significantly down-regulated main effect treatment gene. High levels of
BMP2, 4, and 7 inhibit neurogenesis while low levels of BMP4 promotes survival of
newly generated OSNs (Shou et al., 2000). Although the function of BMP6 in the
nervous system is not well-characterized, the significantly increased expression of Bmp6
in the Lip-C mice compared to Lip-O mice, combined with the significant downregulation at 48 h following OBX in both groups, may act to inhibit basal cell
proliferation in Lip-C mice while promoting proliferation of OSN progenitors and
survival of OSNs at 48 h following OBX. Several Fgf-related genes had significant
pairwise effects, namely Fgf9, Fgf12, Fgf21, Frag1 (FGF receptor activating protein 1),
Fgfr1, Fgfr2, and Fgfr11. Most of these Fgf-related genes were expressed at lower levels
in the Lip-C mice and up-regulated following OBX. Taken together, these data suggest
that while macrophages may not be the sole source of these regulators of basal cell
proliferation, they may regulate the expression of Bmp- and Fgf- -related genes by other
cell types in the OE through signaling of cytokines or other growth factors.
A result of the extracellular molecular regulation of basal cell proliferation is the
differential expression of cell cycle promoters and transcription factors that promote
neurogenesis. As expected, the majority of these genes were expressed at lower levels in
the OE of Lip-C mice compared to Lip-O mice and up-regulated at 48 h following OBX,
which was confirmed by the EASE results. The mRNA for Ccnd1 (cyclin D1), a G1/Sphase cell cycle promoter, has been reported to be up-regulated in the OE as early as 16 h
following OBX and has been localized to basal cells (Getchell et al., 2002b; Shetty et al.,
2005). In our model, Ccnd2 was identified as an interaction gene that had a marginally
down-regulated Lip-C effect and was up-regulated at 48 h following OBX, while other
cyclin-associated genes had various pairwise effects. Consistent with the decrease in
basal cell proliferation associated with macrophage depletion, transcription factors
associated with neurogenesis in the OE were significantly down-regulated in Lip-C mice
compared to Lip-O mice and up-regulated at 48 h following OBX. For example, the
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bHLH transcription factors Neurod1 and Hes6, which are involved in the proliferation
and differentiation of OSN progenitors (Manglapus et al., 2004; Shetty et al., 2005;
Suzuki et al., 2003), in addition to Sox2, a transcriptional promoter of neurogenesis
(Episkopou, 2005), and Ngn1, a member of the OSN progenitor
proliferation/differentiation cascade (Cau et al., 2002), had significantly decreased levels
of expression in the OE of Lip-C mice compared to Lip-O mice. This indicates that the
normal signaling mechanisms needed for basal cell proliferation are decreased as a result
of macrophage depletion in the OE of Lip-C mice.
Following division of globose basal cells, the resulting daughter cells may commit
to one of three possible cellular pathways: 1) the cell may return to the globose basal cell
population; 2) the daughter cell may become an immediate OSN precursor; and 3) the
daughter cell may become a sustentacular cell (Beites et al., 2005; Chen et al., 2004).
Based on the microarray data, and following cellular validation of the significant
microarray expression pattern and localization that suggested HDGF was localized to
basal cells and OSNs, we hypothesize that the daughter cells of globose basal cell
division that are committed to the OSN lineage express HDGF as a survival or
proliferative factor (Fig. 8). HDGF is primarily a nuclear autocrine survival and
proliferative factor for neurons (Everett and Bushweller, 2003; Marubuchi et al., 2006;
Zhou et al., 2004). Therefore, it is possible that, either directly or indirectly,
macrophages regulate the expression of Hdgf in basal cells to promote proliferation,
potentially via LIF signaling. Once the OSN precursor becomes post-mitotic, Hdgf may
be expressed as a survival factor. The characterization of Hdgf and its protein product in
the OE may provide novel insights into additional molecular mechanisms that regulate
proliferation and differentiation of OSN progenitors and survival of OSNs.
A molecule reported to promote the differentiation and maturation of OSN
progenitors is TGF-β (Kawauchi et al., 2004; Schwob, 2002). Our microarray data
indicated that two TGF-β receptors, Tgfbr1 (interaction) and Tgfbr2 (treatment), had
significant pairwise effects. Both receptors were expressed at lower levels in Lip-C mice
compared to Lip-O mice, while Tgfbr1 was significantly down-regulated and Tgfbr2 was
significantly up-regulated at 48 h following OBX. Interestingly, immature and mature
OSNs, and potentially basal cells, were reported to express TGF-βRII in vivo (Getchell et
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al., 2002a). OSNs become mature by projecting their axons to the bulb where they
synapse with second-order mitral and tufted cells. The chemokine receptor CXCR4 has
been reported to be involved in axon guidance and cell migration (Belmadani et al., 2005;
Wang et al., 2006), both of which are required for maturation of OSNs. Based upon the
immunohistochemistry localization of SDF-1, our hypothesis is that activated
macrophages express and secrete SDF-1 that binds to CXCR4 on another cell type within
the OE, possibly OSNs, to aid in the maturation of newly generated OSNs. Cxcr4 mRNA
has been localized in the OE of developing (E15) mice (Schwarting et al., 2006). It is
also likely that macrophages express and secrete RA that binds to OSNs, inducing the
expression of CRABP1 and thus promoting the survival of OSNs.
Summary
While our microarray data, combined with molecular and cellular validation of
selected genes, provides strong evidence for the regulation of these mechanisms of OSN
survival and regeneration, and remodeling of the OE, we have to take into consideration
that macrophages are not the sole source of molecular and cellular regulation of these
mechanisms. As noted above, it has been established that other cell types provide trophic
support for basal cells and OSNs (Schwob, 2002). For example, Suzuki and Takeda
reported that IGF-1 immunoreactivity was localized to sustentacular cells of the rat OE
(Suzuki and Takeda, 2002). Other studies have provided evidence that OSNs, basal cells,
and olfactory ensheathing cells, in addition to sustentacular cells, express molecular
regulators of the proliferation and differentiation of OSN progenitors, including TGF-β,
FGFs, LIF, and OMP (Farbman and Buchholz, 1996; Farbman et al., 1998; Getchell et
al., 2002b; Key et al., 1996). Therefore, our study provides evidence that macrophages,
in addition to other cell types in the OE, regulate the survival of OSNs, and the
proliferation, differentiation, and maturation of OSN progenitors through the expression
of growth, survival, and proliferative factors.
In summary, our results characterize the altered gene expression profiles in the
OE of sham and 48 h OBX mice as a result of liposome-encapsulated clodronate-induced
macrophage depletion. In confirming and building upon previous studies from our
laboratory (Borders et al., 2006; Getchell et al., 2006; Kwong et al., 2004), these gene
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expression profiles indicate that macrophages mediate OSN survival, proliferation and
differentiation of OSN progenitors, and remodeling of the OE through the regulation of
the expression of novel and traditional growth factors, immune modulators, cell cycle
promoters, and pro- and anti-apoptosis signaling molecules.
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CHAPTER FOUR

General Discussion
My dissertation has characterized a novel neuroprotective role of macrophages in
the degeneration/proliferation cycle of OSNs through the identification of the cellular and
molecular mechanisms that occur in the OE as a result of macrophage depletion. This is
the first reported study of depleting macrophages in the OE using the drug liposomeencapsulated clodronate to isolate the functional mechanisms regulated by macrophages
in the unperturbed OE and in the OE at 48 h following OBX. From this I demonstrated
that macrophage depletion in the OE resulted in: 1) increased neuronal death at 48 h
following OBX; 2) decreased OE thickness and numbers of mature OSNs and
proliferating basal cells in sham and 48 h OBX mice; 3) differential expression of a large
number of genes, including immune response, growth factor, cell cycle, cytoskeleton, and
apoptosis genes; and 4) decreased expression of HDGF by basal cells and OSNs at 48 h
following OBX.
When we combine this study with previous studies of the immune system’s
involvement in the response to OBX within the OE (Bauer et al., 2000; Bauer et al.,
2003; Getchell et al., 2006; Getchell et al., 2002b; Getchell et al., 2002c; Kim et al.,
2005; Kwong et al., 2004; Nan et al., 2001; Suzuki et al., 1995), it is quite evident that
macrophages play a very key role in regulating not only the response to OBX in the OE,
but also tissue homeostasis in the unperturbed OE. From my model of macrophagemediated neuroprotection and neurogenesis in the very unique neurogenic environment of
the olfactory system, and in particular the OE, it is possible to identify a number of
pathways by which macrophages may regulate these mechanisms in other models of
neurodegeneration. When we consider the amount of research performed across the
world focused on treating neurodegenerative diseases through the inhibition of specific
mechanisms of the immune response, my model of macrophage-mediated
neuroprotection and neurogenesis is quite intriguing because I have proposed and
characterized novel mechanisms by which macrophages promote the survival and
renewal of OSNs that may lead to therapies for neurodegenerative disorders.
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There are currently numerous drugs aimed at treating and preventing
neuroinflammation as a result of cytotoxic mediators secreted either directly or indirectly
by macrophages and T cells (Gris et al., 2004; Mouzaki et al., 2004; Parihar and
Hemnani, 2004). While many of these drugs have been successful, it is reasonable to
hypothesize that many aspects of the immune system are beneficial in the response to
neuronal damage. It is evident that macrophages are required to clear the cell debris
caused by neuronal damage, as is the case in the OE where activated macrophages
phagocytose apoptotic OSNs following OBX (Suzuki et al., 1995). Clearance of cell
debris allows for the regrowth of resident neurons or the proliferation and differentiation
of new neurons, such as OSNs and their progenitors.
Also, these resident and newly generated neurons must receive molecular cues
from the environment in order to survive and regenerate to their appropriate synapses,
thus maintaining a functional signaling axis. Without these cues, for example growth
factors and neurotrophins, the neurons are unable to survive and/or perform
axonogenesis. Many of these molecular signals are derived in part from immune system
cells, including macrophages and T cells (Nathan, 1987). My work has shown that
macrophages are more than capable of creating an environment conducive to neuronal
survival and renewal by phagocytosing cell debris and providing molecular signals to
OSNs and their progenitors, a process that induces the expression of neurotrophic
mediators and cell cycle promoters within these cell types. In addition to the direct
neuroprotective and neuroproliferative effect of macrophages on OSNs and their
progenitors, my work also demonstrated that macrophages promote neurogenesis and
regrowth by regulating the integrity of the OE through cytoskeletal and extracellular
matrix components.
There are still a few avenues of research that can be taken on the topic of how
macrophages regulate the OSN cycle. For example, in Chapter Two I suggested that the
depletion of macrophages results in not just an increase in apoptosis in the OE, but also a
more rapid apoptosis following OBX. Here I mentioned that this is most likely due to the
decrease in neurotrophic molecules secreted by macrophages acting upon the OSNs that
are undergoing apoptosis and those that have yet to undergo apoptosis. From this, one
could study the effects of macrophage depletion in the OE on the cellular response to
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OBX at multiple time points, including 24 and 72 h following OBX. These times points
would be comparable to those used in other studies characterizing macrophage
infiltration and basal cell proliferation (Nan et al., 2001) and the level of apoptosis
(Cowan et al., 2001) in the OE following OBX. In this case, Lip-C and Lip-O would be
administered every day intranasally and every other day intravenously (Table 4.1).
Macrophage depletion would have to be quantified at these additionally time points and
compared to 48 h. By studying the levels of active caspase-3 immunoreactivity and the
numbers of mature OSNs via immunohistochemistry for OMP in the OE of Lip-C and
Lip-O mice at multiple time points following OBX, one could determine whether
macrophages delay OSN apoptosis or prevent it altogether in select OSNs.
Another avenue of study is the extent to which HDGF regulates OSN survival and
proliferation of OSN progenitors. HDGF has been reported to promote neuronal survival
and proliferation (Everett and Bushweller, 2003; Zhou et al., 2004), and was expressed
by basal cells in sham mice and basal cells and OSNs at 48 h following OBX, as reported
in Chapter Three. Since Hdgf expression increased in Lip-O mice but remained
unchanged in Lip-C mice at 48 h following OBX, coinciding with an increase in
apoptosis in the Lip-C mice compared to Lip-O mice, it would be interesting to test
whether HDGF is directly responsible for the difference in apoptosis, and to what extent.
To do this, one could deplete macrophages as done in this study (Table 2.1), and
administer HDGF on the day of and day after surgery, and test whether the level of active
caspase-3 immunoreactivity in Lip-C mice is decreased compared to Lip-C mice that
receive a carrier-only injection, and compare this to Lip-O control mice. However, since
HDGF is primarily a nuclear growth factor and its extracellular functions and sources are
not well known, another approach could be taken. One could use RNAi (RNA
interference) techniques (Bumcrot et al., 2006), which have recently gained a lot of
attention for alternatives to knockout models and therapeutics, to silence Hdgf in Lip-O
mice and test whether the levels of active caspase-3 immunoreactivity increase over
control levels, and compare this increase to the levels observed in Lip-C mice at 48 h
following OBX.
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Table 4.1. Experimental schedule to determine the temporal effects of macrophage
depletion on apoptosis of OSNs following OBX.
Injection
Injection Volumes and Procedures
Route/Surgery Day 1
Day 2
Day 3 Day 4 Day 5
i.n.
50 μl
50 μl
50 μl
50 μl
i.v.
200 μl
0 μl
200 μl
Lip-O
Surgery
Sham or OBX
Euthanization
24 h
48 h
72 h
i.n.
50 μl
50 μl
50 μl
50 μl
i.v.
200 μl
0 μl
200 μl
Lip-C
Surgery
Sham or OBX
Euthanization
24 h
48 h
72 h
Volumes and days of injections, along with days of surgery and tissue harvesting. Mice
Treatment

would not receive a drug administration on the day of euthanization. Abbreviations: LipO, empty liposomes; Lip-C, liposomes containing clodronate; i.n., intranasal; i.v.,
intravenous; OBX, olfactory bulbectomy.
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One aspect of this mechanism that is vital in our understanding of how HDGF
promotes survival of OSNs and proliferation of OSN progenitors is the signaling pathway
through which HDGF functions. Characterizing how HDGF functions in a
neuroprotective manner would be very beneficial in being able to promote neurogenesis
and neuroprotection in not only the OE but also in neurodegenerative diseases. It is
possible that binding of LIF to its receptor on GBCs, which has been reported to induce
GBC proliferation (Bauer et al., 2000; Bauer et al., 2003; Nan et al., 2001), up-regulates
the expression of Hdgf by GBCs. Other growth factors, including FGFs and TGF-β, have
also been reported to promote the proliferation of basal cells (Schwob, 2002). Several
FGF- and TGF-β-related genes, including their receptors, were identified as significant
interaction or main effect genes, expressed primarily at lower levels in Lip-C mice, as
reported in Chapter Three. Macrophage-induced signaling of these growth factors and/or
LIF on OSN progenitors may lead to the up-regulation of Hdgf as a survival or
proliferative factor.
A different approach to studying the effects of macrophage depletion on OSN
survival and regeneration would be to perform a nerve transection on the olfactory nerve,
rather than performing an OBX. In the case of a nerve transection, the synaptic targets of
the OSN axons remain intact, in contrast to OBX. OBX removes the synaptic targets
permanently, therefore preventing the OSN axons from ever regaining functional status.
This results in the death of the newly generated OSNs after several days. However, in a
nerve transection model, the OSN axons are able to connect to their targets and restore
functionality (Simmons et al., 1981; Simmons and Getchell, 1981a; Simmons and
Getchell, 1981b; Verhaagen et al., 1990). It would be interesting to see if macrophages
promote this axonogenesis of newly generated OSNs, in addition to their proliferation
and survival as characterized in my study. To this end, behavioral analysis of Lip-C and
Lip-O mice could be performed to determine if macrophage depletion leads to decreased
sensitivity to odorants. Based on the cellular and molecular data, it would be expected
that Lip-C mice would have a decreased sense of smell compared to Lip-O mice due to
the decreased numbers of mature OSNs in Lip-C sham mice. This would provide
functional significance to the role that macrophages play in the OSN cycle, and in tissue
homeostasis in the OE.
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As previously mentioned, macrophage activation in the OE following OBX most
likely occurs via the binding of apoptosis ligands, including phosphatidylserine and
cellular adhesion molecules, expressed on the cell surface of dying OSNs to scavenger
receptors on macrophages, namely MSR-1, CD36, and/or SCARB-1. A previous study
from my laboratory utilizing an animal model where the gene encoding MSR-1 was
disrupted demonstrated that following OBX there were decreased numbers of: 1)
macrophages in the OE; 2) activated macrophages in the OE; and 3) BrdU+ basal cells,
compared to wild-type mice (Getchell et al., 2006). The transgenic mice also had
decreased OE thickness following OBX compared to wild-type mice. From this it is
evident that binding of apoptotic OSNs to MSR-1 on macrophages leads to macrophage
activation and subsequent cellular changes within the OE. However, from my study it
appears that MSR-1 is only one of several mechanisms by which apoptotic OSNs bind to
macrophages. It would be interesting to utilize similar CD36 and/or SCARB-1
transgenic mouse models and study the cellular changes in the OE of the transgenic mice
following OBX compared to wild-type mice. One would expect decreased macrophage
recruitment, OE thickness, and basal cell proliferation following OBX, similar to that
observed in the Msr1 transgenic mouse model and in my model of liposome-encapsulated
clodronate-induced macrophage depletion.
As previously stated in Chapters Two and Three, while macrophages clearly
regulate the survival of OSNs and the proliferation and differentiation of OSN
progenitors, other cell types play a large role in this process as well. Sustentacular cells,
olfactory ensheathing cells, OSN themselves, and the olfactory bulb all provide
neurotrophic and neurogenic support for the functional OSNs and their progenitors (Calof
et al., 2002; Calof et al., 1998; Costanzo and Graziadei, 1983; Farbman et al., 1998;
Getchell et al., 2002b; Harding et al., 1977; Key et al., 1996; Schwob et al., 1992; Suzuki
and Takeda, 2002). In many cases of neurodegenerative diseases, other cell types, be
they astrocytes, oligodendrocytes, or T cells, provide additional support or cytotoxicity
for creating an environment conducive to neurogenesis or neurodegeneration,
respectively. This adds to the evidence that the cell types that reside and infiltrate any
environment, whether it’s the OE, brain, or spinal cord, must work in harmony to enable
the system to restore function as quickly and effectively as possible. In most cases of
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neurodegeneration induced by inflammation, astrocytes, macrophages, and T cells act on
one another to create an environment filled with inflammatory and cytotoxic mediators.
This inflammatory process appears to be avoided in the OE, which is most likely due to
the controlled environment where OSNs undergo a controlled programmed cell death
induced from a secondary target, followed by binding of ligands on the apoptotic OSNs
to scavenger receptors on the macrophages, inducing their alternative activation.
My dissertation has provided a strong foundation in developing mechanisms to
regulate the survival of OSNs and the proliferation and differentiation of their
progenitors, and provided an outline to expand on our knowledge of macrophagemediated neuroprotection and neurogenesis in the OE described in Chapters Two and
Three. The clinical implications of these findings are unknown, but it is reasonable to
think that if these findings can be translated into clinical models of neurodegenerative
diseases, they may have an impact as immunotherapies. For example, the main
difference between my model and other models of neurodegeneration is that the OE is
part of the peripheral nervous system whereas most others are in the central nervous
system. Therefore, it is logical to assume that the response of macrophages to OSNinduced apoptosis is different than the response of microglia to Alzheimer’s or other
diseases. One possible avenue of study could be to isolate the peripheral macrophages,
such as those in the OE and underlying lamina propria, and transplant them into the site
of central nervous system damage. This may produce a more anti-inflammatory response
to the disease rather than a detrimental neuroinflammatory condition. In fact,
transplanted macrophages that have been alternatively activated in vitro have been
reported to promote spinal cord recovery and secrete BDNF but not TNF-α (Bomstein et
al., 2003; Rapalino et al., 1998), a sign of alternative activation.
From my study and another study from my lab (Getchell et al., 2006), activation
of macrophages in the OE occurs through the binding of apoptosis signaling ligands on
dying OSNs to scavenger receptors on macrophages, including MSR-1, CD36, SCARB1, and most likely others. This process has been reported to result in the “alternative”
activation of macrophages (Dr. Jekyll), known to be beneficial to tissue, rather than
“classical” activation (Mr. Hyde), which is detrimental to tissue (Figure 4.1; Duffield,
2003; Gordon, 2002), as discussed in Chapter One. Accordingly, the alternative
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activation of macrophages in my model was verified by the identification of a number of
alternative activation markers that were significantly regulated, namely Il13ra1 and
Mrc1. Classical activation of macrophages is needed in most cases of tissue repair, but
too much classical activation results in tissue destruction. Interestingly, classical
macrophage activation and neuroinflammation is observed in the olfactory system of
Alzheimer’s patients (Getchell et al., 2003).
Therefore, if classical activation was blocked a short time after injury, and
alternative activation was initiated by administration of scavenger receptor agonists
(molecules that could activate MSR-1, CD36, and/or SCARB-1) or TH2-type cytokines
(IL-4, IL-13) the immune response to injury could result in a very beneficial combination
of macrophage activation states, leading to tissue repair. Implementation of
immunomodulators, which shift the pro-inflammatory autoimmune responses toward a
beneficial anti-inflammatory “alternative” activation response as seen in my model of the
normal OE, could utilize the beneficial capabilities of macrophages in treating
neurodegenerative and neuroinflammatory diseases. In fact, two immunomodulatory
agents, IFN-β (interferon β) and GA (glatiramer acetate), have been reported to be
effective in clinical trials for the treatment of MS (Goodin, 2000; Jacobs et al., 1996;
Johnson et al., 1995). It is evident that influencing the activation state of macrophages in
neuroinflammatory diseases can develop into potential groundbreaking immunotherapies.
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Figure 4.1. The functions of classically and alternatively activated macrophages.
(Duffield, 2003). In neurodegenerative diseases, including MS and Alzheimer’s,
macrophages appear to undergo classical activation, resulting in neuroinflammation and
tissue destruction. In my model of the normal OE, resident OE macrophages appear to
undergo alternative activation through the binding of apoptosis signaling ligands on
dying OSNs to scavenger receptors on macrophages, resulting in neuroprotection,
neuroproliferation, and tissue restoration through the secretion of growth and survival
factors.
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Another pathway that could potentially translate from the olfactory system to
central nervous system diseases is the regulated expression of Hdgf. As previously
mentioned, HDGF is a neurotrophic factor that has been reported to promote neurite
extension and survival of spinal motor neurons in primary culture and repress cell death
of motor neurons after facial nerve section (Marubuchi et al., 2006). If one could induce
an increase in Hdgf expression in areas of neuronal damage in cases of Alzheimer’s
disease, spinal cord injury, or other neurological disorders, this could potentially, at least
in part, promote recovery and repair. Based on the cellular and molecular data provided
in Chapters Two and Three, increased expression of Hdgf may be achieved through the
administration of extracellular neuropoietic molecules, including LIF, FGFs, and/or TGFβ into the diseased area.
Overall, my dissertation has implemented an innovative way to study the function
of macrophages in the OSN degeneration/proliferation cycle; and characterized novel
mechanisms by which macrophages regulate the survival of OSNs, the proliferation and
differentiation of OSN progenitors, and the structural integrity of the OE to promote
neurogenesis. Through these mechanisms we may better understand the capabilities of
macrophages to promote neuroprotection and neurogenesis, and integrate this
understanding into current and future clinical therapeutics for neurological diseases. So
many individuals have fallen victim to neurological disorders that nearly everyone has
witnessed the pain and suffering inflicted upon these individuals and those close to them.
Neurological disorders do not discriminate; they afflict people of all races, social classes,
and genders. Celebrities such as Christoper Reeve (spinal cord injury), Rita Hayworth
(Alzheimer’s disease) and Richard Pryor (MS), world-reknown scientist Stephen
Hawking (amyotrophic lateral sclerosis), former president Ronald Reagan (Alzheimer’s
disease), and athletes such as Muhammad Ali (Parkinson’s disease) have been icons for
neurological disorders over the past couple of decades, bringing the reality of their
physical and emotional impact into the limelight of society. While these and other
celebrities have garnered most of the attention for these disorders, millions of people
across the globe deal with the physical and emotional anguish associated with
neurodegenerative diseases every day. Even though treatments and therapies have
progressed considerably, there are still many bridges to cross in discovering and
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implementing effective treatments. It is my hope that we may one day say “yes, there is
something that can be done to help them,” and cure the neurological disorder afflicting
our coworker, relative, or friend. My graduate research brings us one step closer to that
dream.
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